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VSUMMARY
A metabolic imbalance exists in progressively malignant tumor ceils that
have a high aerobic glycolysis. The MSV-MDCK-INV ceils are a Moloney
sarcoma virus (MSV) transformed epithelial MDCK ceils, which exhibit
multiple f3-actin rich domains where are localized the hepatocyte growth
factor receptor c-Met, the glyceraldehyde-3-phosphate dehydrogenase and
the N&’/H-exchanger. NHE1. A previous study from the laboratory of Dr
No1 had demonstrated that the autocrine activation of the hepatocyte
growth factor receptor/c-Met tyrosine kinase induces tumor ceil motility by
regulating pseudopodial protrusion. We hypothesized that pseudopodial
ATP produced from glycolysis and proton secreted by NHE1 drives
pseudopodial formation, and modulates the motile character of MSV
MDCK-INV cells.
We present here strong indication of a pseudopodial ATP production by
showing the expression and enrichment of the glycolytic enzymes
hexokinase, phosphoglucose isomerase and aldolase, and the absence of
mitochondrial proteins from f3 actin-rich pseudopodial domains. Glycolytic
enzymes colocalize with [3-actin and phosphorylated c-Met. Incubating celis
in glucose-free medium with or without 2-deoxyglucose, or inhibiting
glycolysis with iodoacetate in high glucose medium decreases the
phosphorylation level of c-Met and leads to the loss of pseudopodia. In
contrast, mitochondrial inhibitors such as oligornycin and antimycin-A do
flot affect this phosphorylation level in high glucose medium but decrease it
in glucose-free medium. Pseudopodial glycolysis was found, in the present
study, to be the main source of ATP required to phosphorylate the kinase
domain of c-Met and lead to the actin remodelling, which were shown to
modulate celi motility.
Inhibition of the Na7Htexchanger with ethylisopropylamiloride in the
absence of bicarbonate and C02 atmosphere leads to a rapid reduction of p
c-Met signal. $ecretion of protons produced by glycolysis may be a
vi
necessary step to drive continuous ATP production required for autocrine c
Met phosphorylation. Our resuits suggest a functional link between
pseudopodia-associated glycolysis, NHE1 proton secretion, and
phosphorylation of c-Met that regulates motility and invasion of MSV
MDCK4NV celis.
Key words: c-Met phosphorylation, actin remodeling, proton secretion,
invasion.
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SOMMAIRE
Un déséquilibre métabolique existe dans les cellules tumorales ayant une
forte glycolyse aérobie. Les cellules MSV-MDCK-1NV sont des cellules
MDCK transformées par le virus du sarcome de Moloney (MSV)
sélectionnées pour leur propriété invasive. Elles présentent des domaines
riches en actine f3 où sont exprimés le récepteur du facteur de croissance
hépatocytaire c-Met, la glyceraldehyde-3-phosphate déshydrogénase et
l’échangeur Na7H NHE1. Des travaux antérieurs à la présente étude ont
démontré que l’activation autocrine du récepteur c-Met module l’activité
motile des cellules tumorales MSV-MDCK-NV en régulant la formation
des pseudopodes. Nous avons fait l’hypothèse que l’ATP produit de
l’activité glycolytique des pseudopodes ainsi que la sécrétion, par NHEI,
des protons produit de l’activité glycolytique pseudopodiale sont impliqués
dans la formation des pseudopodes et l’acquisition du caractère motile des
cellules MSV-MDCK-INV.
Nous présentons ici des indices d’une production pseudopodiale d’ATP en
montrant l’expression ou l’enrichissement des enzymes de la glycolyse
(hexokinase, phosphoglucose isornérase et aldolase) et l’absence des
protéines mitochondriales des domaines riches en actine f3 dans les fractions
pseudopodiales purifiées. Les enzymes de la glycolyse colocalisent avec e-
Met phosphorylé et l’actine f3 des pseudopodes. L’incubation des cellules
dans un milieu sans glucose avec ou sans 2-deoxyglucose et l’inhibition de
la glycolyse par l’iodoacétate dans un milieu riche en glucose diminuent le
degré de phosphorylation de c-Met et entraînent la perte des pseudopodes.
En revanche, les inhibiteurs mitochondriaux tels ciue l’oligomycine et
lantimycine A n’affectent pas ce degré de phosphorylation dans le milieu
riche en glucose mais le diminuent dans le milieu sans glucose. Ces résultats
suggèrent que la glycolyse pseudopodiale est la source principale d’ATP
requise pour phosphoryler localement le domaine kinase de c-Met en
réponse au facteur de croissance hépatocytaire et pour fournir l’énergie
viii
nécessaire au remodelage dtactine impliqué dans le phénomène de motilité
des cellules MSV-MDCK-ll’JV.
L’inhibition de l’échangeur Na/H par I’éthylisopropylamiloride en
l’absence d’ions bicarbonate et de C02 entraîne une réduction rapide du
degré de phosphorylation de c-Met. La sécrétion des protons issus de la
glycolyse peut donc être une étape nécessaire à une production continue
d’ATP, exigée pour l’activation autocrine de c-Met. Nos résultats suggèrent
donc l’existence d’un lien fonctionnel entre la glycolyse associée aux
pseudopodes, la sécrétion localisée des protons par NHE1 et la
phosphorylation de c-Met pour la modulation des activités motile et invasive
des cellules tumorales MSV-MDCK-NV.
Mots clés: phosphorylation de c-Met, remodelage de l’actine; sécrétion de
protons, invasion.
ix
TABLE 0f CONTENTS
Dedication iii
Acknowledgements iv
Summary V
Sommaire vii
Table of contents ix
List of figures xiii
List of abbreviations xv
Aimex xvii
Chapter 1. INTRODUCTION
1.1 CelI proliferation and differentiation
1.1.1 Introduction 2
1.1.2 Proliferation 2
1.1.2.1 Tumor growth and ceil proliferation in vivo 2
1.1.2.2 Celis inculture 4
1.1.2.3 Molecular events in ceil proliferation 5
1.1.2.4 Properties oftumor celis in culture 6
1.1.3 Differentiation 8
1.2 Growth factors
1.2.1 Introduction $
1.2.2 Classification ofgrowth factors 9
1.2.2.1 Platelet-derived growth factor family 9
1.2.2.2 Epidermal growth factor family 10
1.2.2.3 Fibroblast growth factor family 11
1.2.2.4 The Insulin family 10
1.2.2.5 Hepatocyte growth factor 11
X1.2.3 General aspects ofHGF .11
1.2.3.1 Description of function 11
1.2.3.2 Location and control 12
1.2.3.3 Structural classification 13
1.2.4 Growth factor receptors with tyrosine kinase activity 14
1.2.4.1 Hepatocyte growth factor receptor (HGF-R) 15
1.2.4.2 Hepatocyte growth factor/receptor signaling pathways 18
1.3 Energy metabolism in normal and tumor tissues
1.3.1 Aerobic glycolysis ofneoplastic celis: The Warburg effect 19
1.3.1.1 Relationship between respiration and glycolysis 20
1.3.2 General aspects of enzymes in cancer 22
1.3.2.1 The Individual Reactions of Glycolysis 22
1.3.2.2 Glycolytic enzyme pattem in human cancer tissue 26
1.3.3 Anaerobic glycolysis ofneoplastic celis 26
1.3.3.1 Control ofanaerobic glycolysis by proton secretion 28
1.4 Intracellular p11 regulation in normal and tumor tissues
1.4.1 Secretion of protons by normal ceils (pH homeostasis) 28
1.4.1.1 Intracellular aikalinization : normal vs tumor celis 29
1.4.1.2 Extracellular acidification on tumor ceil 30
1.4.1.3 Importance ofNa’7H exchange and intracellular
ph in tumor celis 30
1.4.2 Molecular structure ofVertebrate Na7H exchangers 31
1.4.2.1 Introduction 31
1.4.2.2 Molecular identification of the Na/H exchangers 32
1.4.2.3 Structural features 33
1.4.2.4 The NHE-1 isoforrn 33
1.4.3 Therapeutic potential of inhibitors ofNa/H 35
xi
1.5 Invasion and metastasis
1 .5.1 Introduction .35
1.5.2 Turnor-host interactions during the metastatic cascade 35
1.5.3 The metastatic cascade 36
1.6 Objectives of flic present study 40
CHAPTER 2. Pseudopodial MSV-MDCK-INV glycolysis modulates
the c-Met phosphorylation-dependent ccli motility.
2.1 Summary 47
2.2 Introduction 4$
2.3 Experimental procedures 51
2.4 Resuits 55
2.5 Discussion 60
2.6 References 64
CHAPTER 3. DISCUSSION
3.1 Study overview $2
3.2 Biochcmica] characterization of tumor ccli pseudopodia $2
3.3 3-actin rich tumor ccli pseudopodia: Role ofglycolysis 85
3.4 Phosphorylated c-Met induces tumor ccli motility by regulating
pseudopodial protrusion $6
3.5 Glycolysis as primary energy source in tumor ccli chemotaxis $7
3.6 Ccli migration requires botli ion transiocation and cytoskeletal
xii
anchoring by the Na-H exchanger .89
3.7 Glycolysis and tumor ccli motility 91
3.8 Conclusion and perspectives 92
REFERENCES 95
xiii
LIST 0F FIGURES
CHAPTER 1 Introduction
Figure 1.1 Celi cycle: A schematic overview
Figure 1.2 Model ofcell showing the sequence ofevents following
ligand binding to growth factor receptors.
Figure 1.3 HGF binding to the HGf-R’Met tyrosine kinase receptor
leads to activation of different signaling pathways
Figure 1.4 Pathway of glycolysis from glucose to pyruvate
Figure 1.5 Schematic representation of the TCA cycle showing
enzymes, substrates and products
Figure 1.6 The general topology and regulatory sites ofthe Na7H
exchanger.
Figure 1.7 Tumbling down the metastatic cascade
Figure 1.8 13-Actin-rich pseudopodia of MSV-MDCK-LNV celis are
highly blebbed as visualized by scanning electron
rnicroscopy
Figure 1.9 Immunofluorescent distribution of GAPDH in MSV
MDCK-INV ceils.
Figure 1.10 NHE1 is localized to b-actin-rich pseudopodia in MSV
MDCK-INV ceils.
CHAPTER 2 Article
Figure 2.1 Colocalization ofglycolytic enzymes with p-c-Met in f3
-actin rich pseudopodia ofMSV-MDCK-fl’W celis
Figure 2.2 Pseudopodia ofM$V-MDCK-INV celis are divoided
from Mitochondrial proteins
xiv
Figure 2.3 Glycolytic enzymes are present or concentrated in
pseudopodial fraction, and mitochondrial proteins are
absent
Figure 2.4 Glycolytic activity regulates the actin dynamics and the
phosphorylation level of c-Met
Figure 2.5 Phosphorylation degree of c-Met is higher in high
glucose medium
compared to a glucose-free one
figure 2.6 Treatment with iodoacetate in high glucose medium
resuits in a clear shortening and broadening of
pseudopodia similar to that observed in low glucose
medium
figure 2.7 Treatrnents with oligomycin or antimycin in glucose
free compared to high glucose medium induced the lost
ofpseudopodia, and appearance of multiple membrane
blebs
Figure 2.8 Inhibition of Na+, H+exchange activity decreases c
Met phosphorylation
Figure 2.9 The wound healing linked to the motile character of
INV ceils is significantly decreased in the absence of
glucose
CHAPTER 3 Discussion
Figure 3.1 The Iink between 13-actin, glycolytic enzymes, c-Met
and NHE 1 in regulating ceil motility
xv
LIST 0f ABBREVIATIONS
ALDO Aldolase
ATP Adenosine triphosphate
CB Celi body
c-Met Tyrosine kinase receptor for hepatocyte growth
factor
2-DG 2-Deoxyglucose
EIPA Ethylisopropylamiloride
ERK Extra-cellular signal regulated kinase
FGF Fibroblast growth factor
G3PDH Glyceraldehyde-3-Phosphate dehydrogenase
HGF Hepatocyte growth factor
HGF-R Hepatocyte growth factor receptor
HK Hexokinase
LAA Iodoacetate
IGF Insulin-like growth factor
INV Invasive
kDa Kilodalton
LDH Lactate dehydrogenase
xvi
MDCK Madin Darby canine kidney
MSV Moloney sarcoma virus
NHE1 Isoform 1 ofthe Na, H exchanger
Oligo Oligomycin
PDK1 Mitochondrial pyruvate dehydrogenase kinase
PGI Phosphoglucose isomerase
pHe Extracellular pH
pHi Intracellular pH
Pi liorganic phosphate
PK Pyruvate kinase
PPF Pseudopodia fraction
RTK Receptor tyrosine kinase
SF Scatter factor
TOM-20 20 kDa preprotein transiocase of the outer membrane
xvii
Annex
Joseffe No1 My research supervisor. She directed ail the experiments.
With her advice and suggestions, she participated in the
design and the correction of the manuscript.
1. Robert Nabi He allows us the use of the confocal microscopy. He made
suggestions and correction on the manuscript.
Zong Jiang Jïa He gave me advice conceming the pseudopod purification
technique. He instructed me on how to use the confocal
microscopy.
Yolaine Dodier and Zeinab Daher They made the experimentation
concerning the inhibition of the Na/H exchanger with
EIPA (Figure 2.9)
Carlos El Hader I performed ail the experirnents including: celi
culture, drug treatrnents, immunofluorescence, confocal
rnicroscopy, pseudopod and ceil body purification, western
blotting, ATP dosage by luminometry, c-Met quantification, and
wound healing assays. I perfonned the writing of the manuscript
designed in collaboration with rny supervisor.
CHAPTER 1
INTRODUCTION
21.1 Ceil proliferation and differentiation
1.1.1 Introduction
The biology of ceil division and differentiation is exceedingly similar in
normal and cancer ceils. The cancer ceil differs from its normal counterpart in
that it is aberrantly regulated. Cancer cells generally contain the full
complement of biomolecules necessary for survival, proliferation,
differentiation, and expression of many celi-type-specific fiinctions. However,
failure to regulate these functions properly results in an altered phenotype,
which often leads to cancer (1).
Three cellular functions tend to be inappropriately regulated in a neoplasm:
First, the normal constraints on cellular proliferation are relaxed (2). This is a
necessary but often insufficient requirement for tumor formation. Second,
differentiation can be distorted. The tumor cells may be blocked at a particular
stage of differentiation, or they may differentiate into an inappropriate or
abnormal cell type (3). Third, chromosomal and genetic organization may be
destabilized such that variant cells arise with high frequency. Some variants
may have an increased growth advantage, others may be resistant to killing by
chemotherapeutic drugs or radiation and others may have increased motility
or production of enzymes that permit invasion and metastases (4).
1.1.2 Proliferation
1.1.2.1 Tumor growth and ceil proliferation in vivo
In terms of population kinetics, the growth of any tissue depends on three
parameters: 1) rate of individual cell division, 2) growth fraction of the ceil
population and 3) cdl loss from the growing population through
differentiation or cell death.
3In an organism, the rate of ceil division is a tightly regulated process that is
intimately associated with growth, differentiation and tissue turnover.
Generally, ceils do not undergo division unless they receive signais that
instnict them to enter the active segments of the ceil cycle. Resting cells are
said to be in the G0 phase (quiescence) ofthe ceil cycle (Figure 1.1).
Figure 1. Schematic representation of the mammalian ce!! cycle.
Competence factors such as PDGF and FGF promote entry into the early G1
phase. Sequential treatment with progression factors, IGF or EGF, promote
progression through the G1 phase restriction point. Competence of the cyclin
Dl/Cdk4 complex is induced by mitogens. The cyclin D1/Cdk4 complex
phosphorylates the pRB protein leading to sequentiai phosphorylation by
cyclin E/Cdk2 and release of free E2f. The phosphorylation of pRB and relief
of transcriptional repression by pRB induces genes involved in the induction
Figure adaptedftom (S)
4The signais that induce celis to divide are diverse and trigger a large number
of signal transduction cascades. Generally, signals that direct ceils to enter the
cell cycle are called growth factors, cytokines, or mitogens.
Normal cells reach a steady state of growth that provides a balanced economy
for the body as a whole. Each organ maintains tight control over the growth
rate, growth fraction, and cell loss. Some normal tissues grow faster than
cancers under physiologie conditions, so it is flot simply rapid growth at a
single time and place that distinguishes neoplasia.
In the early phases of turnor cell growth, it is generally believed that
neoplastic cells multiply exponentially, then as the tumor mass increases, the
rate of growth declines (6). Several mechanisms have been invoked to explain
this change in growth rate with larger tumors: 1) decrease in the growth
fraction, 2) increase in cdl loss or death, 3) nutritional depletion of tumor
cells due to outgrowth of available blood supply, or 4) lengthening of cdl
cycle time (7). Experimental tumor models suggest that cell cycle time
changes only slightly when tumor growth decreases (1). Under adverse
conditions, tumor cells oflen leave the growth fraction and enter a non
growing state (Go or prolonged G1) although these same celis can reenter the
division cycle when conditions improve or when stimulated by growth factors.
1.1.2.2 Celis in culture
The importance of the individual cdl in cancer is clear since a single cancer
ccli injected into an appropriate animal is sufficient to give rise to a tumor.
Many studies have therefore been performed with isolated normal and tumor
celis in culture. Both normal and tumor-derived mammalian cells can be
grown and compared in culture, although many are not readily established in
culture initially (8-li). Most studies have been done on fibroblasts since this
cdl type is easily cultured and is most likely to grow out of a tissue explants.
5Cells are grown in a medium containing salts, amino acids, glucose, vitamins,
and senim or growth factors. Normal celis, plated on a plastic surface to
which they may attach, can grow until they have forrned a confluent
monolayer, whereupon growth ceases. Growth also ceases when ceils have
exhausted an essential nutrient or factor provided by serum, or when such
substances are removed by changing to a deficient mcdium. Thus, growth can
be manipulated in culture.
1.1.2.3 Molecular events in ce!! proliferation
When a quiescent cell in culture is stimulated, for example by the addition of
serum, the activated chain of events leads eventually to formation oftwo cells.
This requires duplication of a multitude ofmolecules in the original cdl (12).
Multiple growth factors provided in serum have been found to act sequentially
following resumption of proliferation of fibroblasts: platelet-derived growth
factor (PDGF), epidermal growth factor (EGF), insulin-like growth factor
(IGF-1), and hepatocyte growth factor (HGf) (13). These small polypeptides
activate cells by binding to specific receptors on the cdl surface (13, 14).
Growth factor receptors are complex large proteins that span the plasma
membrane. On the outside of the cell they have a specific domain that
recognizes the growth factor, and their cytoplasmic portion may have an
enzymatic function, such as protein tyrosine kinase. Binding of a growth
factor or ligand to its receptor can induce transmission of a signal to the
cytoplasm through activation ofthe kinase (15) (Figure 1.2). The next step is
the transduction of the cytoplasmic signal to cell nucleus (16). This is
accomplished by a heterogeneous group of molecules known as second
messengers. They include various proteins that are phosphorylated by kinases
such as transcription factors, small molecules such as inositol phosphates and
cyclic AMP, and also ions, including Ca2, H, and Zn2. Within the nucleus,
genes are then activated in response to these second messengers.
61.1.2.4 Properties of tumor cells in culture
Tumor and normal ceils can be distinguished in culture by several tests.
Tumorigenic cells are less sensitive to the presence of other ceils in their
immediate vicinity than are normal celis. Normal cells typically cease
proliferation as the culture density increases, but turnor ceils can reach
several-fold higher densities in culture. If they are plated on a dense layer of
non proliferating, homogenous normal cells, tumor cells can continue to grow
and form foci of clustered cell colonies. Such colonies show altered
interactions by the tumor cells, which grow randomly, criss-crossing one
another and forming clusters of viable and necrotic celis. When these cultures
are fixed and stained, number of tumor colonies is easily quantitied against the
background population of normal cells. This is the basis of the commonly
used “focus forming assay” also called “anchorage independent growth” for
detecting transformation, e.g., the capacity of mutagens or oncogens to
produce neoplastic transformation within a population of non tumor ceils (3).
Cells of normal solid tissue lie on a secreted extracellular matrix (ECM),
cornposed of various proteins that stimulate ceil growth (17). Transformed
celis are ofien partly or cornpletely independent of ECM for optimal growth,
and they may secrete littie matrix material (18). In addition the cytoskeleton
within tumor cells tends to be less well organized, and its actin filaments are
less highly polymerized. Tumor cells often can be grown in the absence of a
substratum, as within a semisolid medium containing agar. This formation of
colonies in suspension is also used as a test ofneoplastic transformation (3).
7Fi%ure 1.2: Model of ceil showing the sequence of events following ligand
binding to growth factor receptors.
Figure adaptedfrom (19)
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81.1.3 Differentiation
Ail tumor celis show abnorrnalities in the regulation of ceil proilferation
(neoplasia). In addition, most, if flot ail, tumor celis show abnormalities in
differentiation (anapiasia). The anaplasia of tumors can provide insights into
their etiology, degree of malignancy, prognosis, and sensitivity to therapeutic
intervention by differentiation or maturation-inducing agents (3).
It is obvious that although somatic ceiis are geneticaily equal they are flot
phenotypically equal. Thus, skin fibroblasts are different from T lymphocytes,
muscle cells differ from gastric mucosal cells, and so forth. However, within
an organism, all ceils have an identical complement of DNA. Differences in
phenotype arise from differences in gene expression, not in gene content (3).
1.2 Growth factors
1.2.1 Introduction
The evolution of multiceiiular organisms has involved the development of
intercellular communication required for such processes as embryonic
developrnent, tissue differentiation, as well as systemic responses to wounds
and infections. These complex signaiing networks are in large part mediated
by growth factors, cytokines and hormones. Such factors can influence cell
proiiferation in positive or negative ways as well as inducing a series of
differentiated responses in appropriate target cells. The interaction of a growth
factor with its receptor by specific binding in tum activates a cascade of
intracellular biochemical events that is ultimately responsible for the
biofogical responses observed. Cytoplasmic molecules that mediate these
responses have been tenued second messengers. The eventual transmission of
biochemical signals to the nucleus leads to effects on the expression of
cassettes of genes involved in mitogen and differentiation responses (20).
9Over the past few years it has become increasingly evident that the pathogenic
expression of criticai genes in growth factor signaling pathways can
contribute to aitered ceil growth associated with malignancy. The v-sis
oncogene of simian sarcoma virus, which encodes a growth factor
homologous to the B chain of human platelet derived growth factor (PDGF
B), is the paradigm for such genes (21, 22). The normal homologs of other
oncogenes have been shown to encode membrane spanning growth factor
receptors (23, 24). Other genes that act eariy in intracellular pathways of
growth factor signal transduction, for example ras, have been implicated as
oncogenes as weli. Present knowledge indicates that the constitutive
activation of growth factor signaling pathways through genetic alterations
affecting these genes contributes to the deveiopment and progression of most
if not ail human cancers.
1.2.2 Classification of growth factors
Growth factors are proteins that bind to receptors on the cell surface, with the
primary resuit of activating ceiiuiar proiiferation andlor differentiation. Many
growth factors are quite versatile, stimulating cellular division in numerous
different cell types, while others are specific to a particular ceii type (20).
1.2.2.1 Platelet-derived growth factor family
Platelet-derived growth factor is a cationic protein that consists of two reiated
but non-identicai polypeptide chains designated A and B (also caiied PDGF-1
and PDGF-2), which is the major growth factor in human serum (21, 22).
PDGF molecules exist as AA and BB homodimers as weii as an AB
heterodimers (25, 26). PDGF-AB is the major PDGF form found in platelets
and is released into serum upon blood clotting. Efforts to identify factors that
control angiogenesis recently led to the identification of a new growth factor,
the vascular endothelial growth factor (VEGF), that is a potent mitogen for
vascular endothelial cells of small and large vessels, but has no effect on
10
fibroblasts, lens epithelial ceils, comeai endothelial celis, keratinocytes, or
adrenal cortex cells (21). VEGF was shown to be a critical factor which
stimulates neovascularisation of tumor ceils, in that way, favoring the
deveiopment ofmetastasis.
1.2.2.2 Epidermal growth factor family
EGF purified from mouse sub-maxillary glands was found to promote
precocious eyeiid separation by enhancing epidermal growth and
keratinization while it induced eariy incisor eruption by eiihancing the
differentiation of the lips of treated animais (27). Other members of the EGF
family including tumor growth factor-a (TGF-a), amphiregulin (AR) and
poxvirus growth factors share sequence similarities, high binding affinity to
the EGF receptor and mitogenic effects on EGF-responsive celis. EGF is
normally expressed in kidney and sub-maxiiiary glands and is produced in
response to GI tract injury (27, 28) as well TGF-Œ appears to be normally
expressed by a variety of epithelial ceils (29).
1.2.2.3 Fibroblast growth factor family
There are seven known members of the fibroblast growth factor (FGF) family,
whose targets include celis derived from mesoderm and neuroectoderm.
Because heparin can bind to and modulate the biological activity of these
proteins, they have aiso been termed heparin-binding growth factors (HBGFs)
(30, 31).
1.2.2.4 The insulin family
The diversity of metabolic effects of insulin has been studied intensiveiy for
decades (32). Its primary in vivo functions involve the regulation of rapid
anaboiic responses such as glucose uptake, lipogenesis and amino acid and
ion transport. Besides its effects on metabolism, insulin stimulates DNA
synthesis and ceii growth. The activities of insuiin-like growth factors (IGF-I
11
and IGF-II) were first recognized as serum factors, antigenically distinct from
insulin, that interacted with growth hormone in stimulating growth of skeletal
tissues and were, as a resuit, termed somatomedins (33). Subsequently it was
determined that somatomedin C is identical to IGF-I, while a polypeptide
known as multiplication stimulating factor (MSA) is homologous to IGF-IT.
1.2.2.5 Hepatocyte growtli factor
A growth factor apparently specific for hepatocytes (HGf) was isolated from
plasma (34) or platelets (35). Unexpectedly, the predicted amino acid
sequence of HGF was found to be related to plasminogen (36). In addition to
the 38% sequence identity to plasminogen, including its serine protease
domain within the alpha chain, HGF was shown to possess disulfide bond
linked intrachain structures known as “kringles” which are typical of
prothrombin. Neither plasminogen nor plasmin have HGf-like activity, and
HGF is flot likely to be a protease since the histidine and serine residues in the
region corresponding to the catalytic site are replaced by other amino acids.
1.2.3 General aspects ofHGF
Hepatocyte growth factor (HGf) is a heparin binding, secreted basic protein
(37) initially identified as a potent hepatotrophic factor responsible for
vigorous regeneration of the liver. It has become a well-characterized
multipotent growth factor (more properly called a cytokine) with biological
functions that reach far beyond the original identifications, operating in
virtually every tissue of the body (3$). Cellular targets include hepatocytes
and other epithelial celis (e.g. lens epithelial celis) melanocytes, endothelial
and haematopoietic celis.
1.2.3.1 Description offunction
HGf, the natural ligand for the c-Met proto-oncogene product, is a
mesenchymal- or strornal-derived multipotent polypeptide that mediates
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epithelial-mesenchymal interactions (39). During embryogenesis, HGF
stimulates celi proliferation (e.g. placental cytotrophoblasts), differentiation,
motility and invasiveness via its membrane-spaiming tyrosine kinase receptor,
c-Met. HGf induces angiogenesis, is involved in haematopoiesis,
chondrogenesis, and supports organogenesis and morphogenesis (40) of
various tissues and organs, including the liver, kidney, lung, mammary gland,
tooth, skeletal system, etc. In aduit tissues, HGF elicits a potent organotrophic
function, which supports regeneration of organs including the liver, kidney,
and lung.
HGF has been shown to play a pivotal role in integrin-mediated adhesion and
transmigration of neutrophuls to sites of acute inflammation through
cytoskeletal rearrangement (41). In neoplastic tissue, HGF is involved in
tumor invasion and metastasis, through tumor-stromal interactions. Studies
have shown anti-tumor activity for certain species of carcinoma celis, and in
particular, growth of most hepatoma cells is inhibited by HGF.
1.2.3.2 Location and control
HGF is the ligand for the transmembrane tyrosine kinase (c-Met), and is
initially secreted as a single-chain, biologically inert glycoprotein precursor
(pro-HGF) (38). Under appropriate conditions, pro-HGF is converted into its
bioactive form by proteolytic digestion; four proteases are reported to activate
HGF within the so-called dibasic site (uPA) , a serine protease. This
processing takes place in the extracellular environment; cleaving of the
zymogens induces a conformational change in the ligand, and
interactionlactivation of the receptor follows. The HGF precursor can also be
processed by a senim-derived serine protease. This soluble glycoprotein,
known as HGF activator, may bring about quantitative activation of pro-HGF
in response to the triggering of the blood coagulation cascade, as in the case of
tissue injury, whereas uPA may effect a more restricted activation of the
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precursor in the tissues and on the membrane of target ceils under conditions
other than trauma or injury (42).
Expression of HGF at the transcription level is regulated by various factors.
Interleukin- 1, platelet-derived growth factor, acidic and basic fibroblast
growth factor, epidermal growth factor, and prostaglandin’s are potent
inducers of HGF expression (39). Polysaccharides, such as heparin and
heparan-suiphate, stimulate HGF synthesis, but only affect post
transcriptional processes (39, 40). In fact heparin is crucial for inducing HGF
dimerization (3-6 fold higher levels). Moreover, the fact that cellular
responses to HGF depend on glycosaminoglycan composition of the ceil
membrane further supports the hypothesis that receptor activation requires a
co-operative participation of multiple surface and soluble components (38). In
contrast, transforming growth factor-131 and glucocorticoids suppress the gene
expression of HGf, acting transcriptionally (39).
1.2.3.3 Structural classification
Mature HGF is a heterodimer with a 69-kDa a-chain and a 34-kDa 13-chain,
linked by a single disuiphide bridge (43). The Œ-chain contains the N-terminal
hairpin structure and 4 homologous “kringle dornains”, the first of which
carnes receptor-binding determinants (38). Although the kringle domain (80
amino acids) is thought to play a role in protein-protein interaction, its
physiological function is unknown (44). However, a hydrophobic core and a
distinct folding pattem determined by 3 intramolecular disulphide bonds,
characterize the dominant structural feature. The 13-chain lias serine protease
like motif (37) and thus lias structural homology (3 8%) with plasminogen but
2 arnino acid residues are different at the “protease active site11 conferring it no
biological activities.
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1.2.4 Growth factor receptors witli tyrosine kinase activity
Membrane spanning tyrosine kinase receptors contain severaÏ discrete
dornains including their extra cellular ligand binding, transmembrane,
juxtamembrane, protein tyrosine kinase and carboxy-terminal tau domains
(45, 46). Interaction of a growth factor with its receptor at the cell surface
leads to a tight association, so that growth factors are capable of mediating
their activities at low nanomolar concentrations. following ligand binding, the
growth factor-receptor complex is internalized leading to increased turnover
of the receptor. It has been proposed that the growth factor activation signal
might be mediated by its internalization (46). However, there is substantial
evidence that activation of the receptor tyrosine kinase is the trigger for the
biochernical cascade of events that follows. It is possible that conformational
changes induced by ligand binding to the receptor’s external domain are
somehow transrnitted through the transmembrane domain to induce the
conformational alterations of the receptor kinase resulting in its activation (45,
46). li an alternative model more generally accepted, ligand binding induces
receptor dimerization or oligomerization (46). By this latter mechanism,
molecular interactions between adjacent cytoplasmic domains lead to
activation of kinase function.
The tyrosine kinase domain is the most conserved a;nong tyrosine kinase
receptors and an intact protein tyrosine kinase domain is absolutely required
for receptor signaling. For example, mutation of a single lysine in the ATP
binding site (45), which blocks the ability of the receptor to phosphorylate
tyrosine residues, completely inactivates receptor biological ftinction. Yet,
such kinase mutants retain the ability to bind ligand with high affinity and
exhibit normal internalization and down regulation as well (45).
The carboxy terminal domain of the receptor is thought to play an important
role in regulation of kinase activity. This region typically contains several
tyrosine residues, which are phosphorylated by the activated kinase. In fact,
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the receptor, itself, is ofien the major tyrosine phosphorylated species
observed following ligand stimulation. Tyrosine phosphorylation of the
carboxy terminal domain has been postulated to modulate kinase catalytic
activity, an&or the ability of the kinase to interact with substrates. Thus,
mutations, which alter individual tyrosine sites or deletions of the carboxy
terminal domain, have the effect of attenuating kinase ftinction in those
receptors so far analysed (45, 47).
1.2.4.1 Hepatocyte growth factor receptor (HGF-R)
The receptor for HGF, the c-met protooncogene (4$), is a transmembrane
protein that is derived from a 1 70-kDa precursor. Afler processing by furin
(49), the mature c-met is composed of a 50-kDa c’ subunit that is linked by 2
disulfide bonds to a 145-kDa B subunit (50). The Œ subunit is extracellular and
heavily glycosylated, whereas the B subunit consists of an extracellular portion
to which HGF binds, a membrane spanning dornain, a distinctive
juxtarnembrane domain, a cytoplasmic tyrosine kinase domain and carboxy
terminal sequences acting as a docking site for adaptors (Figure 1.3).
Autophosphorylation of the tyrosine residues in positions 1230, 1234, 1235
has a positive regulatory effect on the enzyme activity whereas
autophosphorylation of a serine residue in position 1003 in the
juxtarnembrane domain negatively regulates the kinase (3$). The carboxy
terminal portion includes the tyrosine residues 1359 and 1365 that, when
phosphorylated, together form a specific docking site for multiple signal
transducers and adapters. Growth factor receptor-bound protein 2 (GRB2)
binds preferentially to the second tyrosine residue and triggers the ras signal
transduction pathway (32).
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Figure 1.3: HGF binding to the HGF-RJMet tyrosine kinase receptor
leads to activation of different signalïng pathways. HGF, upon binding to
its receptor c-met, induces its dimerization as well as autophosphorylation of
tyrosine residues. Phosphorylation of tyrosine residues within multifunctional
site triggers a pleiotropic response involving multiple signal transducers. The
synchronous activation of several signaling pathways is essential to conferring
the distinct invasive growth ability of the HGF receptor. In epithelial ceils,
HGF functions as a scattering (dissociation!motility) factor.
figttre adaptedftom (51)
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The polypeptide growth factor hepatocyte growth factor/scatter factor
(HGF/$F) (44, 52-54) and its receptor MET, the product of the c-MET proto
oncogene (55), play essential roles in the developrnent of epithelial organs
such as the placenta and liver (56, 57) and in the migration of myogenic
precursor ceils (58) and motor neurons (59, 60).
HGF/SF and MET are also involved in the spreading of a variety of epithelial
tumors as a resuit of MET chromosomal rearrangements (61), somatic and/or
germ une mutations in the MET kinase (62) or, more oflen, over expression in
tumor ceils of an unreananged and unmutated MET gene (63).
Met signaling clearly has a role in normal cellular processes. When this
signaling pathway is deregulated, it is implicated in tumor development and
progression. Met signaling can increase tumorigenicity, induce ceil motility,
and enhance invasiveness in vitro and metastasis in vivo (56, 64, 65). In
addition, Met signaling can increase the production of protease and urokinase,
which are associated with extracellular matrix/basal membrane degradation
and are important for metastasis (66).
Following c-Met activation by HGF in tumor celis, phosphorylation of beta
catenin occurs, together with loss of intercellular adhesion and a gain in the
motile and invasive nature of the celi. It was shown that c-met is co-localized
with beta-catenin and E-cadherin at regions of cell-cell contact in MCF7 and
MDA MB 231 BCC unes (transformed mammary celi unes).
Immunoprecipitation studies demonstrated an association between c-met and
members of the cadherin adhesion complex in these epithe1ia tumor ceils,
along with the membrane tyrosine protein phosphatase, PTPmu (67).
Activating Met mutations leading to increased levels of tyrosine
phosphorylation and enhanced kinase activity toward an exogenous substrate
when compared with wild type Met could contribute to papillary renal
carcinoma and other human malignancies (56, 68). Mutant Met induced
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motility of Madin-Darby canine kidney celis and metastasis of NIH 3T3 celis
while transgenic mice expressing the oncogenic form of Met developed
metastatic manmiary carcinoma.
1.2.4.2 Hepatocyte growth factorireceptor signaling pathways
Foïlowing c-Met dimerization and autophosphorylation of tyrosine residues,
various adaptors and signal transducers bind to the docking site’s
phosphorylated residues. Interaction of growth factor receptor bound protein
2 (Grb2), gabl (Grb-2 associated binder 1), p$5-Pl3kinase, phospholipase C
y (PLC y), the isoform 3 of signal transducer and activator of transcription
factor (STAT-3) and the $rc homology/collagen (SHC) protein via Src
homology domain 2 (SH2) triggers various signal transduction pathways
(Figure 1.3). The synchronous activation of several signaling pathways is
essential to conferring the distinct invasive growth ability of the HGF
receptor.
HGF functions as a scattering (dissociationlmotility) factor for epithelial celis,
and this ability seems to be mediated through the activation of STAT-3
(Miller and Padanilam 2001). Phosphorylation of adhesion complex
regulatory proteins such as ZO- 1, 3 catenin, and focal adhesion kinase (FAK)
may occur via activation of c-src. Another Bc12 interacting protein termed
BAG-1 mediates the antiapoptotic signal of HGF receptor by a mechanism of
receptor association independent from tyrosine residues. Akt phosphorylation
through the Pl3kinase pathway also participates in the anti-apoptotic action of
c-Met (51)
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1.3 Energy metabolïsm in norma] and tumor tissues
1.3.1 Aerobic glycolysis of neoplastic cetts: 11w Warburg effect
A metabolic imbalance exists in progressively malignant tumor ceils. The
observation that rapidly growing tumor celis have a high aerobic glycolysis
was first reported by Warburg (69), who considered that elevated glycolysis
was a consequence of impairment in the respiratory mechanism of celis
caused by carcinogens. Warburg noted that in ail of the tumors he examined
respiration was iow and glycolysis was high. In Warburg’s proposai, the
carcinogenic agent is presumed to interfere with cell respiration and the celi
either dies or adopts a fermentative mechanism to derive energy necessary for
survival. The carcinogenic agent, whether it is a virus, anaerobiosis, X-ray, or
chemical carcinogen, is presurned to damage respiration either by interfering
with the extent of respiration or by impairing the effect of respiration,
rendering it incapable of suppressing glycolysis. Warburg’s theory implied
that damage to respiration should be ineversibie, but as yet there has flot been
an unequivocai demonstration that the respiration of tumors is distributed.
following Warburg’s initial observation ofa low rate of respiration in tumors,
it was demonstrated that in some turnors the rate of respiration is normal and
that severai none-cancer tissues have appreciable rates of aerobic glycolysis,
such as the retina, leucocytes, kidney, medulia and intestinai mucosa (70).
Mitochondria from neoplastic tissues have a full complement of the enzymes
of the citric acid cycle and also functional respiratory pigments, which serve
as the components ofthe electron transport chain (71). Further, as emphasized
by Weinhouse (72), neoplasms exhibit a normal Pasteur effect when measured
in terms of the Meyerhof oxidation quotient, that is, the oxygen, which is
consumed by malignant cells, is just as effective in quantitatively inhibiting
the formation of glycolysis end products as that consumed by normai tissues.
One of the most potent arguments against the Warburg’s hypothesis is the
demonstration that the malignant celis respire at rates, which do not appear to
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differ from that of their normai counterpart. Thus aerobic glycolysis is flot
necessariiy an essential feature ofmaiignancy.
Despite the failure to observe a unique biochemical pattern of energy
metabolism in ail tumor celis, a correlation of growth rate with increasing
glycoiysis is observed in the hepatoma series (73). However, the question as
to whether this is related to the primary event in oncogenesis is unanswered.
Racker (74) has proposed a new hypothesis, which focuses on “the findings of
Warburg as a significant feature of cancer pathogenesis”. He proposes,
“Tumors can be caused by a number of different primary lesions” ail of which
“have in common the ability to cause a persistent alteration in the intracellular
pH thereby upsetting the normal reguiatory mechanism that prevents
uncontrolled growth”. Thus the so-cailed Warburg effect remains, and, in this
authors opinion, is deserving of further study in view of the reported
correlation between growth rate and glycoiysis (73). The increased aerobic
glycolysis may reflect cellular alterations, which favor growing ceils.
1.3.1.1 Relationship between respiration and glycolysis
Before discussing possible explanations for an elevated aerobic glycolysis, it
is perhaps useful to discuss the regulation of carbohydrate metabolism,
particuÏarÏy the interrelationships of respiration and glycolysis. The
fttndamentai controls, which operate on these processes at the celiuiar levei,
are part of the basic system on which the action of extemal controls, such as
hormones and growth factors, is superimposed.
Inhibition of glycolysis by oxidative phosphorylation is known as the Pasteur
effect. The uncouplers of oxidative phosphorylation reverse the inhibition of
glycolysis, indicating that phosphorylation of ADP by inorganic phosphate
(75) and not respiration is important to the control mechanisrn. As pointed out
by Racker, the Pasteur effect is expiained as follows: “the enzymes of
glycolysis can metabolize glucose oniy when (a) inorganic phosphate and
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ADP are available for the oxidation of glyceraldehyde-3-phosphate, and (b)
the ATP: ADP ratio and the concentration of Pi and other ailosteric effects of
glycolytic enzymes are suitable for catalytic action” (74).
Some key enzymes of glycolysis are reguiated allosterically by the ATP: ADP
ratios as weii as by Pi levels. As first demonstrated by Bucher and Russman
(76), the key enzymes subject to regulation are those whose substrates and
products are displaced from equilibrium in the ccli. As an example, the
phosphofructokinase reaction is inhibited by high concentrations of ATP but
stimulated by Pi. further, inorganic phosphate reverses product inhibition of
hexokinase-l by glucose-6-phosphate; aiso, inorganic phosphate as well as the
NAD: NADH ratio regulates the oxidation of giyceraldehyde-3-phosphate.
The NAD: NADH ratio is dependent on the availability of an electron
acceptor such as pyruvate, and pyruvate formation from phosphoenolpyruvate
is dependent on ADP availability. k is thus apparent that the levels of ATP,
ADP, and Pi determine the rate of giycoiysis by their interaction at several
key steps in the fermentation scherne (70).
The rate of respiration is also markedly dependent on the availabiiity of ADP
and Pi and this dependence is known as respiratory controi. Thus the cofactors
of the phosphoryiation system are common to both giycolysis and respiration.
Further, there is competition between these two systems for ADP and Pi,
which are in Iimited supply. As a chemical work (e.g., biosynthesis) or an
osmotic work such as ion transport (e.g. Na and K by the Na pump) is
performed, energy is utilized and ADP and Pi become availabie for further
generation of energy. The inhibition of glucose utiiization by oxygen then is
attributed in part to the iesser availabiiity of cofactors of the phosphorylation
system under aerobic conditions (70).
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1.3.2 Generat aspects ofglycolytic enzymes in cancer
One of the most notable developments in biochemistry during the past 50
years has been the recognition and description of the individual enzymes that
mediate the various steps ofintermediary metabolism in tissues.
1.3.2.1 The individual reactions of glycolysis
The pathway of glycolysis adapted from King et al., (Figure 1.4) can be seen
as consisting of 2 separate phases
The first is the chemical priming phase requiring energy in the form of ATP,
and the second is considered the energy-yielding phase. In the first phase, 2
equivalents of ATP are used to convert glucose to fructose 1 ,6-bisphosphate
(Fi, 6BP). In the second phase Fi, 6BP is degraded to pyruvate, with the
production of 4 equivalents ofATP and 2 equivalents ofNADH.
Some of the enzymes catalyze the reaction in one direction as, for example,
glucokinase (or hexokinase IV) and hexokinase I, II, and III mediating the
interaction of glucose with ATP to form glucose 6-phosphate, whereas the
reverse reaction is mediated by glucose 6-phosphatase. Many other enzymes
catalyze reversible reactions, and equilibrium is attained no matter from which
direction the reaction is started.
The hexokinase reaction: The ATP-dependent phosphorylation of glucose to
form glucose 6-phosphate (G6P) is the ftrst reaction of glycolysis, and is
catalyzed by tissue-specific isoenzyrnes known as hexokinase. The
phosphorylation accomplishes two goals: First, the hexokinase reaction
converts nonionic glucose into an anion that is trapped in the cytoplasm, since
cells lack transport systems for phosphorylated sugars. Second, the otherwise
biologically inert glucose becomes activated into a labile form capable of
being further metabolized.
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Fiure1.4: Pathway of glycolysis from glucose to pyruvate. Substrates and
products are in blue; enzymes are in green. The two high-energy intermediates
whose oxidations are coupled to ATP synthesis are shown in red. Under
aerobic conditions, pyruvate in most celis is further metabolized via the ICA
cycle. Under anaerobic conditions pyruvate is converted to lactate by the
enzyme tactate dehydrogenase (LDH), and the lactate is transported out of
the ce!! into the circulation. figitre adaptedftom (77)
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Phosphohexose isomerase: The second reaction of glycolysis is an
isomerization, in which G6P is converted to fructose 6-phosphate (F6P). The
enzyme catalyzing this reaction is phosphohexose isomerase (also known as
phosphoglucose isomerase). The reaction is freeÏy reversible at normal
cellular concentrations of the two-hexose phosphates and thus catalyzes this
interconversion during glycolytic carbon flow and during gluconeogenesis.
6-Phosphofructo-1-kinase (phosphofructokinase-1, PfK-1): The next
reaction of glycolysis involves the utilization of a second ATP to convert F6P
to fructose 1,6-bisphosphate (fi, 6BP). This reaction is catalyzed by 6-
phosphofructo-1-kinase, better known as phosphofructokinase-1 or PFK-1.
This reaction is not readily reversible because of its large positive free energy
tAG0 = +5.4 kcal/mol) in the reverse direction. Nevertheless, fructose units
readily flow in the reverse (gluconeogenic) direction because of the
ubiquitous prescnce of the hydrolytic enzyme, fructose-1, 6-bisphosphatase
(F-l, 6-BPase).
Aldolase: Aldolase catalyses the hydrolysis of Fi, 6BP into two 3-carbon
products: dihydroxyacetone phosphate (DHAP) and glyceraldehyde 3-
phosphate (G3P). The aldolase reaction proceeds readily in the reverse
direction, being utilized for both glycolysis and gluconeogenesis
Triose phosphate isomerase: The two products of the aldolase reaction
equilibrate readily in a reaction catalyzed by triose phosphate isomerase.
Succeeding reactions of glycolysis utilize G3P as a substrate; thus, the
aldolase reaction is pulled in the glycolytic direction by mass action.
Glyceraldehyde-3-phosphate dehydrogenase: The second phase of glucose
catabolism features the energy-yielding glycolytic reactions that produce ATP
and NADH. In the first of these reactions, glyceraldehyde-3-phosphate
dehydrogenase (G3PDH) catalyzes the NADtdependent oxidation of G3P to
1,3-bisphosphoglycerate (l,3BPG) and NADH. The G3PDH reaction is
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reversible, and the same enzyme catalyzes the reverse reaction during
gluconeogenesis.
Phosphoglycerate kinase: The high-energy phosphate of 1,3-BPG is used to
form ATP and 3-phosphoglycerate (3PG) by the enzyme phosphoglycerate
kinase. Note that this is the only reaction of glycolysis or gluconeogenesis that
involves ATP and yet is reversible under normal celi conditions. Associated
with the phosphoglycerate kinase pathway is an important reaction of
erythrocytes, the formation of 2,3BPG by the enzyme bisphosphoglycerate
mutase. 2,3BPG is an important regulator of hemoglobin’s affinity for
oxygen. Note that 2,3-bisphosphoglycerate phosphatase degrades 2,3BPG to
3-phosphoglycerate, a normal intermediate of glycolysis. The 2,3BPG shunt
thus operates with the expenditure of 1 equivalent of ATP per triose passed
through the shunt. The process is flot reversible under physiological
conditions.
Phosphoglycerate mutase and enolase: The remaining reactions of
glycolysis are aimed at converting the relatively low energy phosphoacyl-ester
of 3-PG to a high-energy form and harvesting the phosphate as ATP. The 3-
PG is first converted to 2-PG by phosphoglycerate mutase and the 2-PG
conversion to phosphoenolpyruvate (PEP) is catalyzed by enolase
Pyruvate kinase: The final reaction of aerobic glycolysis is catalyzed by the
highly regulated enzyme pyruvate kinase (PK). In this strongly exergonic
reaction, the high-energy phosphate of PEP is conserved as ATP. The loss of
phosphate by PEP leads to the production of pyruvate in an unstable enol
form, which spontaneously tautomerizes to the more stable, keto form of
pyruvate. This reaction contributes a large proportion of the free energy of
hydrolysis ofPEP.
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1.3.2.2 Glycolytic enzyme pattern in human cancer tissue
Because of the high glycolytic activity of tumors and the assumption that the
activities of glycolytic enzymes might be elevated in turnors, Warburg and
Christian (7$) conceived the possibility that the blood leaving the tumor and
entering the general circulation might show elevation of serum glycolytic
enzymes. Indeed, they found that serum aldolase activity was elevated in rats
bearing the Jensen sarcoma. These observations were confirmed by $ibley and
Lehuinger (79) who, in addition, extended the studies to human cancer.
Since these early studies, other enzymes in the glycolytic sequence and,
indeed, in other metabolic sequences have been studied with regard to their
appearance in human serum and their elevation in patients with cancer.
$everal factors may be involved in the elevation of a serum enzyme activity in
cancer: 1- the damage of membranes of tumor cells or normal cells, so that
one or more enzymes pass into the extracellular fluid and then into the
circulation, 2- the size of the tumor or organ which is damaged and the
concentration of enzymes in the tumor or normal organ and 3- the rate of
disappearance of the enzyme from the circulation, whether by rnetabolisrn or
by excretion. Elevations in serum enzyme activities may be characterized by
varying degrees of specifity.
1.3.3 Anaerobic glycolysis of neoplastic celis
Under aerobic conditions, acetyl-CoA in most celis is ftirther metabolized via
the TCA cycle (Figure 1.5). Under anaerobic conditions and in erythrocytes
under aerobic conditions, pyruvate is converted to lactate by the enzyme
lactate dehydrogenase (LDH), and the lactate is transported out ofthe celi into
the circulation. The conversion of pyruvate to lactate, under anaerobic
conditions, provides the cell with a mechanism for the oxidation of NADH
Qroduced during the G3PDH reaction) to NAD, which occurs during the
LDH catalyzed reaction. This reduction is required since NAD is a necessary
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Figure 1.5: Schematic representation of the TCA cycle showing enzymes,
substrates and products. The abbreviated enzymes are: IDH = isocitrate
dehydrogenase and cx-KGDH = a-ketoglutarate dehydrogenase. The GTP
generated during the succinate thiokinase (succinyl-CoA synthetase) reaction
is equivalent to a mole of ATP by virtue of the presence of nïtcÏeoside
dthosphokinase. The 3 moles of NADH and 1 mole of fADH2 generated
during each round of the cycle feed into the oxidative phosphorylation
pathway. Each mole of NADH leads to 3 moles of ATP and each mole of
FADH2 leads to 2 moles of ATP. Therefore, for each mole of acetyl-CoA,
which enters the TCA cycle, 12 moles ofATP can be generated.
figitre adaptedftoin (77)
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substrate for G3PDH, without which glycolysis will cease. Normally, during
aerobic glycolysis the electrons of cytoplasmic NADH are transferred to
mitochondrial carriers of the oxidative phosphorylation pathway generating a
continuous pool of cytoplasmic NAD.
Aerobic glycolysis generates substantially more ATP per mole of glucose
oxidized than does anaerobic glycolysis. The utility of anaerobic glycolysis to
a celi when it needs large amounts of energy stems from the fact that the rate
of ATP production from glycolysis is approximately 1 OOX faster than from
oxidative phosphorylation. Cells do flot need to energize anabolic reaction
pathways. The requirement is to generate the maximum amount of ATP in the
shortest time frame.
1.3.3.1 Control of glycolysis by proton secretion
There are several factors, which can contribute to the availability of the
phosphorylating system and to the control of energy states in the cdl. Aerobic
glycolysis of glucose to pyruvate requires two equivalents of ATP to activate
the process, with the subsequent production of four equivalents of ATP and
two equivalents of NADH. Thus, conversion, of one mole of glucose to two
moles of pyruvate is accompanied by the net production of two moles each of
ATP and NADH and 2 protons ($0).
1.4 Intracellular pH regulation in normal and tumor tissues
1.4.1 Secretion of protons by normal ceils (pH homeostasis)
The maintenance of an appropriate pH within mernbrane-enclosed
compartments is a constant challenge for all living beings, from the simplest
prokaryotes to complex multicellular organisms. Accordingly, cells have
evolved a variety of specialized proton-translocating devices ($0).
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ht mitochondria, cytochromes exploit the flux of electrons to extrude protons,
thus producing a proton gradient that is used to generate useftil chemical
energy in the form of ATP. Other organelles consume ATP to pump protons
into the lumen to generate the acidic pH required for the maturation and
processing of secretory proteins and for the dissociation and recycling of
endocytosed materials. Proton-exchanger, ionophores of interest, allows an
efficient extraction andlor release of cations by a simple control of the pH
($0).
1.4.1.1 Intracellular aikalinization: normal vs tumor celis
Measurement of pH in vivo has shown that the microenvironment of tumors is
generally more acidic than in normal tissue, with median pH values of about
7.0 for tumors and 7.5 for normal tissue (69, 81, $2). The studies ofWarburg
in the early part of the century (69) showed that tumor ceils preferentialïy
convert glucose and other substrates to lactic acid, even under aerobic
conditions (83). Since then, positron emission tomography (PET) and
magnetic resonance spectroscopy (MRS) have consistently demonstrated the
increased use of glycolysis in tumors (84-87). The increased use of the
glycolytic pathway matched with the compromised vasculature of a tumor
results in the poor removal of lactic acid and is believed to be the main cause
of acidity within solid tumors (88).
Traditionally, most estimates of pH in tissue were obtained by insertion of
pH electrodes (81). These were usually quite large in comparison to a tumor
celi (83), and primarily measured interstitial or extracellular tissue pH. for
rnost purposes, the parameter of interest is intracellular pH (pHi), and since
lactic acid production can lead to intracellular acidosis, tumors were thought
for many years to have a more acidic pHi (89). However, with the advent of
MRS imaging for non-invasive measurements of pHi (83), both human and
animal tumor cells have been shown to have intracellular pH similar to
normal celis, near neutrality (pH 7.0) (88, 90), or even slightly alkaline (pH
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7.1-7.2) (89, 91). This gives rise to a reversed pH gradient across the celi
membrane between normal tissues and tumors.
1.4.1.2 Extracellular acidification on tumor celi
Despite the more acidic tumor microenvironment, most in vitro experiments
are stili performed at the relatively alkaline extracellular pH (pHe) of 7.4. This
is significant because slight changes in pHe can have profound effects on ceil
phenotype (92). It has been shown that the metastatic potential of tumor ceils
depends directly on the degree of acidification (93). More specifically studies
by Martinez-Zaguilan and co-workers (92) have shown that the incubation of
human melanoma cells under conditions of low pHe causes them to become
more invasive and migratory. Furthermore, tumor angiogenesis may be
regulated by pH. The switch to the angiogenic phenotype depends on a net
balance of positive and negative angiogenic factors released by the tumor.
Recent evidence from several laboratories (94-96) support a role for pH in this
process, and indicate that tumor ceils at low pH, increase the expression of
positive angiogdnic factors, such as vascular endothelial growth factor
(VEGF) and interleukin-8 (IL-8), probably in order to increase the vasculature
ofthe tumor.
1.4.1.3 Importance of Nat’H exchange and intracellular pH in tumor
celis
Proper regulation of intracellular pH (pHi) is critical for the optimal function
of almost every biologic process. In many cell types, pHi is regulated
primarily by a family of Na/ff’ exchangers (NHEs), transmembrane proteins
that mediate the electroneutral exchange of an intracellular proton for an
extracellular sodium ion. NHEY was the first Na/H exchanger isoform to be
cloned and sequenced in 1989 (97). Since then, rnuch effort has been directed
to identifying novel members of the Na/H exchanger family and
31
understanding their roles in a range of physiologie and pathophysiologic
cellular processes, from cellular proliferation to apoptosis (98, 99).
The Na/H exchanger has been recently examined in several models of
human turnors. They suggest that, in at least some celi types, the Na7H
exchanger and intracellular pH regulation associated with this protein play an
important role in tumor ceil growth (100). Early studies showed that the
Na7H exchanger deficient ceils (101) lost or severely reduced their capacity
to grow tumors in vivo in immune deficient mice. In addition, a variety of
evidence suggested that activation of the Na/H exchanger and the resultant
increases in intracellular pH may be required for mitogenesis in some celi
types (98). In HC03 free media, Na7H exchanger deficient cells caimot
proliferate in media of low extemal pH (101). In addition, extracellular Na is
limiting in growth factor-dependent proliferation (102), and amiloride and its
analogs can block changes caused by growth factor stimulation, especially in
HC03 free or low Na medium (103).
Because of the important role of the Na7H exchanger in tumor and cell
growth, arniloride and its analogs have been tested for use in tumor selective
therapy.
1.4.2 Molecular structure of vertebrate Na/H exchangers
Na/H exchangers (NHE), also called antiporters, are vital transmembrane
transporters involved in multiple cellular functions including the regulation of
intracellular pH, the control of ceil volume and transepithelial ion transport
(104, 105).
1.4.2.1 Introduction
Na7H antiport (exchange) is one of the primary mechanisms involved in the
extrusion of H from vertebrate celis. Originally described by Murer et al.,
(106) in vesicles from brush-border membranes of kidney tubules, the
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transporter has since been identified in the plasma membrane of virtually all
eukaryotic cells. Biochemical studies and, more recently, molecular cloning
have provided increasing evidence about the structure, functional features and
regulation of the Na7H exchangers, referred to as NHE (107). Na7H
exchangers are integral plasma membrane proteins that catalyze the
electroneutral exchange of extracellular Na for intracellular H with a
stoichiometry of one for one. An essential feature of these exchangers is their
altosteric activation by intracellular protons, which are presumed to interact at
a ‘modifier’ site that is separate from the sites involved in Na and H
transport (107).
The activity and expression level of the exchangers can be modulated by a
remarkably wide variety of stimuli, including growth factors, tumor
promoters, hormones (107) and chronic extracellular acidification (108), as
well as by physical factors, such as changes in ceil volume (109) or cell
spreading (110). The most widely studied NHE isoform, NHE-1, is
ubiquitously expressed and is involved in a variety of cellular functions by
virtue of its ability to govern intracellular pH. It is inhibited by the diuretic
compound arniloride and by the 5-amino-substituted derivatives of amiloride.
Besides NHE- 1, many other isofonns, initially characterized by their lower
sensitivity to amiloride, have been identified and cloned, principally in
epithelia where they perform more specialized ion transport (NHE-2, NHE-3,
NHE-4, NHE-8). NHE-6 and NHE-7 are specialized isoforms involved in
organelle pHi regulation and Na transport (99).
1.4.2.2 Molecular identification ofthe Na17H exchangers
Using a genetic strategy, Sardet et al., (1989) were the first to identify a
Na7H exchanger isoform fully by cloning a hurnan cDNA encoding the
amiloride-sensitive growth-factor-activatable Na’7H antiporter. This cDNA,
cloned by complementation of a Na7H antiport-deficient cell line, was
shown to restore fully the biochemical and physiological features of the
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transporter, namely pHi regulation, when transfected into antiporter-deficient
ceils. This human exchanger cDNA, now referred to as NHE-1, is
ubiquitously expressed in tissues and celis and, in polarized epithelial ceils,
generally resides in the basolateral membrane, although exceptions have been
reported (11 1). Pharmacological, kinetic and regulatory properties of Na7H
exchangers in various ccli types, tissues and species had predicted the
existence of multiple isoforms ofNa17H exchangers (112).
1.4.2.3 Structural features
On the basis of their hydropathy profiles, all Na/H exchangers exhibit
similar topologies. The molecule has two separate functionai domains: an N-
terminal hydrophobic domain (made up of 10—12 membrane-spanning
domains) with approximately 500 amino acids, and a C-terminal hydrophilic
domain with around 300 amino acids (Figure 1.6). The N-terminal
transmembrane part of NHE- 1 is necessary and sufficient to catalyze the ion
exchange, whereas the cytoplasmic C-terminal domain determines the pH set
point value of the exchanger and is crucial for mediating the activation of the
exchanger by growth factors, hormones and hyperosmotic stress (113).
1.4.2.4 The NHE-1 isoform
Amiloride and its 5-amino-substituted derivatives are reported to inhibit the
transporter by competing with Na for its extemai binding site (114). The
amiloride-binding site appears to be iocated in the N-terminal domain of the
exchanger since NHE- 1, afier rernoval of the entire cytoplasmic domain,
remains sensitive to amiloride (113). NHE-1 is the isoform that is most
sensitive to amiloride and its analogues (103, 115).
Most mitogens activate the NHE-1 isoform, leading to an intracellular
alkalization (107), most easily detectable in the absence of bicarbonate (116,
117). At least three groups have reported that mitogenic agents activate the
antiporter by shiffing the pH-dependence of the modifier site, adjusting the set
34
point upwards by 0.15—0.30 pH units (118-121). As a resuit, the exchanger is
activated, but only temporariiy, returning to near quiescence when
intracellular pH (pHi) attains the new set point value.
NHEI
Figure 1.6: The general topology and regulatory sites of the Na+/H+
exchanger. The Na/H exchanger is comprised of 12 transmembrane
domains. The long cytosolic tau lias 3 subdomains: one for regulation by
internai ATP levels, which may invoive changes in PIP2 levels in the adjacent
membrane, a second that includes a “calmodulin autoinhibitory domain” and
the iast that contains phosphorylation consensus sequences which are either
directly phosphorylated by cytoplasmic kinases or through accessory proteins.
PIP2 = phosphatidylinositol 4,5 -bisphosphate.
figttre adaptedfto;n (105)
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1.4.3 Therapeutic potential of inhibitors of Na/H exchanger
Since Na7H exchange plays an important role in regulation of intracellular
pH (pHi) and is essential for homeostasis of celis, inhibitors of the exchanger
might influence the viability andlor proliferation of both normal and tumor
celis.
Amiloride, a potassium-sparing diuretic, is known to inhibit the activity of the
Na/H exchanger by binding to the antiport at a site on the extracellular side
of the membrane. Kleyman and Cragoe showed that analogs of amiloride such
as EIPA or HMA were more potent and more specific inhibitors of Na7H
exchange activity than amiloride. EIPA was found to inhibit completely the
Na’7H exchange activity (122).
1.5 Invasion and metastasis
1.5.1 Introduction
Metastatic spread of cancer celis greatly compounds the severity of the
disease since it can resuit in secondary tumors developing in vital organs and
could be one ofthe main contributing factors to cancer mortality (123)
1.5.2 Tumor-host interactions during the metastatic cascade
Clinically it has been observed that while large numbers of cancer ceils can be
shed into the circulation, only very few of these celis will resuit in clinically
apparent metastases. Once cancer celis separate from the primary tumor and
enter the circulation, the vast majority of them would quickly be destroyed in
the circulation during transport to the secondary site and I or in the
microcirculation afier their arrest. Factors involved in this destruction could
include homodynamic forces and the immune system in immunocompetent
animals (124).
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Various steps in the metastatic process have been believed to contribute
significantly to this inefficiency of each tumor ceils released to develop a
secondary tumor. First, properties of the celis in the primary tumor can
detennine the likelihood of metastases developing, including the tendency and
ability of ceils to escape from the primary tumor and intravasate into the
circulation. Second, the circulation has been believed to be a particularly
hostile environment for cancer celis, the vast majority of which had thought to
be destroyed by hemodynamic forces. Third, the ability to extravasate has
been considered a major rate-limiting step in metastasis, which few celis that
arrive in a new capillary bed thought to be able to escape from the circulation
into the surrounding tissue. Fourth, ceils that successfully extravasate need to
be able to adhere to a different tissue and grow in the new site including a
requirement for induction of new bïood vessels in order for the tumor to grow
beyond small size (124).
End point analysis, histological examination and electron micrographs have
been used to formulate theories of metastasis. It was considered that cancer
celis were arrested in venules that have diameters much larger than their own.
Two different theories described how cancer cells moved into the surrounding
tissues afler becoming arrested in the microcirculation (125). One view is that
cancer ceils began dividing intravascularly used proteases to destroy the
sunounding vascular basement membrane, and they literally divided their way
into the surrounding tissues where they continued to replicate (125). A second
view is that cancer cells behaved more like leukocytes and could extravasate
singly without the destruction of micro vascular walls, using pseudopodial
projections to move either between or through the endothelial ceils (125).
1.5.3 The metastatic cascade
The inefficiency of tumor cells in completing the metastatic cascade( adapted
from the Cancer principles and practice of oncology; 6th edition) (Figure 1.7)
is the resuit of the fact that successful formation of metastatic foci consists of
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several highly complex and interdependents steps. Each step is rate limiting in
that failure to complete any of these events completely disrupts metastasis
formation. Metastasis is thought to be similar in ail tumors and is
characterized as follow:
1- Oncogenesis (tumorigenesis). After the initiai neopiastic transformation,
often by a virus, the tumor ceils undergo progressive proliferation that is
accompanied by further genetic changes and development of a heterogeneous
tumor ceIl population with varying degrees of metastatic potential. The initiai
growth of the primary tumor is supported by the surrounding tissue
microenvironment, which eventually becomes rate limiting for ftirther growth.
2- Angiogenic switches. As the tumor grows and central turnor ceils become
hypoxic, the tumor initiates recruitment of its own blood supply. This process
is called the angiogenic switch and involves the secretion of various
angiogenesis inhibitors. Vascuiarization of the tumor is aiso associated with a
dramatic increase in the metastatic potential ofthese tumors.
3-Cionai dominance and invasive phenotype. A continued genetic alteration in
the tumor celi population results in selection of tumor celi ciones with distinct
growth advantage and acquisition of an invasive phenotype. Invasive tumor
celis down—regulate ceil-cell adhesion, alter their attachment to the
extracellular matrix (ECM) by changing integrin expression profiles and
proteoiytically alter the matrix. Collectively, these changes result in enhanced
cell motility and the ability of these invasive cells to separate from the
primary tumor mass. These celis can detach from the prirnary tumor and
create defects in the ECM that define tissue boundaries, such as basement
membranes, thus accomplishing stromal invasion. furthermore, the pooriy
formed turnor vasculature that forms in response to the angiogenic switch in
phenotype of the primai’,’ tumor, as well as thin walled iymphatic channels in
the surrounding stroma, are readily penetrated by these invasive tumor ceils
and offer ready conduits to the systemic circulation. Endothelial ceiis
38
responding to the angiogenic stimulus produced by the primary tumor also
express an invasive phenotype.
4- Surviving in the circulation. Once the tumor celis and tumor clumps
(emboli) have reached the vascular or lymphatic compartments, they must
survive a variety of hemodynamic and immunologie challenges. Littie is
known about how these factors may impact on the inefficiency of the
metastatic process in human cancers.
5- Tumor celi arrest. After survival in the circulation, tumor ceils must arrest
in distant organs or lymph nodes. This arrest may occur by size trapping on
the inflow side of the microcirculation, or by adherence of tumor cells through
specific interactions with capillary or lymphatic endothelial celis, or binding
to exposed basement membrane.
6- Extravasation and growth at the secondary site. In most cases, arrested
tumor cells extravasate before proliferating. Studies suggest that extravasation
of tumor cells are flot dependent on protease activity and are independent of
metastatic potential. Afier exiting the vascular or lymphatic compartments,
metastatic tumor cells may proliferate in response to paracrine growth factors
or become dormant. After extravasation, tumor cell migrate to a local
environment more favorable for their continued growth. Findings using in
vivo videomicroscopy demonstrate that the poor growth of tumor cells afier
extravasation from the circulation is a major factor contributing to the
inefficiency of the metastatic process.
7- Angiogenesis in metastatic foci. finally continued growth of the metastatic
foci is also dependent on angiogcnesis. The development of this neovascular
network at the metastatic site enhances the metastatic potential of these cells
just as it does for the primary tumor.
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8- Evasion of immune response. Metastatic foci of tumor celis must evade
eradication by immune responses that may be either nonspecific or targeted
directly against the tumor celis.
Basement
membrane
Growth at new
site
Figure 1.7: Tumbling down the metastatic cascade. After breaking off
from the prirnary tumor (far left), cancer ceils travel through the blood
vessels. Those that reach a secondary site such as the lung (right) may
colonize it and form a metastasis.
figure adapted [rom (126)
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1.6 Objectives ofthe present study.
The MSV-MDCK-INV (INV) were selected from Moloney sarcoma virus
(MSV) transformants of the polarized epithelial MDCK celi une for their
capacity to pass through a Matrigel® —coated filter unit (Figure 1.8). llTV
celis exhibit multiple pseudopodia, no visible actin stress fibers and f3-actin
rich dornains at the tips of pseudopodia where is concentrated the hepatocyte
growth factor receptor (HGF-R) otherwise known as the c-Met proto
oncogene (127). Moreover, the glyceraldehyde-3-phosphate dehydrogenase
(G3PDH) (figure 1.9) and the Na7Htexchanger NHE1 (Figure 1.10) from
INV celis were found to colocalize with actin in pseudopodia, the site of
dynamic actin polymerization.We hypothesized that a pseudopodial ATP
would be involved in modulating c-Met activation, motility and invasion of
TNV ceils.
Given the demonstrated role of glycolysis as a primary energy source for
tumor celi motility, and the role of c-Met phosphorylation in modulating
cancer ceil invasion (128) and pseudopodial protrusion (12$), we were
interested in investigating the mechanism underlying the critical role of
glycolysis in tumor ceil rnotility, which is to drive the formation and
protrusion of tumor celi pseudopodia. We took advantages of the improved
pseudopod purification technique which gives hundred of ig of pseudopodial
proteins to determine the content in glycolysis enzymes (hexokinase, aldolase,
phosphoglucose isomerase) and mitochondrial proteins (PDK-1 and TOM 20)
relative to j3-actin and p-c-Met in cell bodies and total ceil lysates. It was of
interest to estimate the phosphorylation state of c-Met in conditions where cell
ATP concentration was rnodulated by the use of different media and
inhibitors. We performed several experiments intending to specifically
decrease the concentration of ATP produced from glycolysis by using
iodoacetate, or ATP produced from mitochondria by using antimycin A and
4oligomycin. To assess whether ATP from mitochondrial respiration is also
required for the formation of 3 actin rich pseudopodia, INV ceils were
incubated with oligomycin or antimycin in high glucose and glucose-free
media
. It was also of great interest to investigate the phosphorylation level of
c-Met in the presence of an inhibited NHE- 1. And finally to ascertain that the
glycolytic ATP production within pseudopodia of INV ceils is necessary to
drive celi motility, wound-healing assays were realized to estimate the motile
capability of ENV celis in conditions shown to modulate c-Met
phosphorylation level.
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Figure 1.8: f3-Actin-rich pseudopodia of MSV-MDCK-INV celis are
highly blebbed as visualized by scanning electron microscopy. MSV
MDCK (A, C) and MSV-MDCK-INV (B, D—H) ceils plated on a glass
substrate (A—D) or on 1-tm-pore filters (E—H) were prepared for scanning
electron microscopy. Distinctive blebbed pseudopodia are present in MSV
MDCK-INV cells (3, D) which are not present in MSV-MDCK (A, C) ceils
plated on a substrate. The upper side of the filter (E) presents numerous ceil
bodies while on the lower side of the filter (f—H) numerous protrusions have
passed through the filter pores, the majority of which present the same
blebbed morphology as the pseudopodia of MSV-MDCK-JNV ceils plated on
a substrate. (A, E, f), bar, 25 prn; (B, C, G) bar, 10 jim; (D, H) bar, 1 tm.
figt,reftoi;i (129).
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Figure 1.9: Immunofluorescent distribution of GAPDH in MSV-MDCK
INV celis. MSV-MDCK-INV ceils were double immuno-fluorescently
Ïabeled for anti-GAPDH (A) followed by FITC-conjugated anti-mouse
secondary antibodies together with actin using Texas red phaÏ]oidin (130).
Merged images are presented with actin in red and GAPDH (E) in green as
indicated. GAPDH labeling can be observed in the actin-labeïed tips of MSV
MDCK-INV pseudopodia, although the majority of GAPDH labeling is
present in the ceil body.
Figitrefrom (129)
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Figure 1.10: NHE 1 is localized to f-actin-rfch pseudopodia in MSV
MDCK-INV ceils. (A,B) MDCK, (C,D) MSV-MDCK and (E,F) MSV
MDCK-INV ccli unes were immunofluorescentiy labeled with polycional
anti-NHEY (A,C,E) and monoclonal anti-13-actin (B,D,F) antibodies. NHE1 is
uniformly distributed in MDCK and MSV-MDCK ceils, whereas in MSV
MDCK-TNV celis it is also localized at the tips of pseudopodia, where it
colocalizes with 13-actin. Bar, 10 jim.
fit,re from (131)
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2.1 Summary
MSV-MDCK-INV (INV) ceils were selected for their invasive character from a
Moloney sarcoma virus-transformed celi une (MSV-MDCK). They present
multiple 13-actin rich pseudopodia where are localized the glycolytic enzyme
GAPDH, the Na,H-exchanger NHE1, and the phosphorylated c- Met,
activated via an autocrine HGf loop. We identified a pseudopodial ATP and we
examined whether this ATP produced by glycolysis and the protons secreted by
NHE1 drive pseudopodial formation and the motile character of TNV ceils.
Hexokinase, phosphoglucose isomerase and aldolase were detected in
pseudopodia and colocalized with f3-actin and phosphorylated c-Met (p-c-Met).
Mitochondrial proteins were absent from actin-rich pseudopodial domains.
Iricubating celis in glucose-free medium with or without 2-deoxyglucose, or
inhibiting glycolysis with iodoacetate in high glucose medium decreases the
phosphorylation level of c-Met and lead to the loss of pseudopodia. In contrast,
mitochondrial inhibitors such as oligomycin and antimycin-A do not affect c
Met phosphorylation in high glucose medium but decrease it in glucose-free
medium and more than that induce bleb formation. Together, these results
indicate a preference for ATP production from glycolysis to maintain
pseudopodial phosphorylation of c-Met and actin remodelling, which were
shown to modulate celi motility (Vadnais et al., J. Biol. Chem. 277: 48342-50,
2002). Inhibition of the Na,H exchanger with ethyl-isopropy-amiÏoride in the
absence of bicarbonate, reduce the pHi by 0.7 unit (Lagana et al., J Ceil $ci,
113: 3649-3662. 2000),and leads also to a rapid reduction of c-Met
phosphoryaltion. Secretion of protons produced by glycolysis may be a
necessary step to drive continuous ATP production required for the localized
autocrine c-Met phosphorylation in pseudopodia. Our resuits suggest a
functional link between pseudopodia-associated glycolysis, NHE1 proton
secretion, and phosphorylation of c-Met to regulate cell rnotility and invasion of
MSV-MDCK-TNV cells.
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2.2 Introduction
Up regulation of multiple glycolytic enzymes (132) and increase in glucose
transport (133) is associated with tumor rnalignancy. Glycolysis was found to be
the primary energy source in tumor cells (134), exceeding the capacity of
mitochondrial oxidative energy metabolism (135). It was also shown to regulate
the protrusion of the multiple pseudopodia, and thereby the motility, of tumor
celis (129). Glycolytic enzymes have long been described to associate with the
actin cytoskeleton enabling the compartmentalization of these energy
generating enzymes to selected cytosolic locations (136). Glycolytic enzymes
distribution correlates with celi-cycle associated changes in the F-actin
cytoskeleton suggesting that glycolytic activity may regulate actin cytoskeleton
organization (137).
The Met receptor tyrosine kinase is the prototypic member of a srnall subfamily
of growth factor receptors (13$). The growth factor that binds and activates Met
is commonly named HGF/SF as it was identified independently as both a
growth factor for hepatocytes (HGF) and a fibroblast-derived celi motility
factor, scatter factor (SF) (55, 139, 140). Following ligand binding and
autophosphorylation, c-Met transmits intracellular signais using a unique
multisubstrate docking site present within the C-terminal end of the receptor
(13$, 141-145). Autophosphorylation ofthe tyrosine residues at positions 1234-
1235 has a positive regulatory effect on the enzyme activity; where as
autophosphorylation of a serine residue in the juxtamembrane domain
negatively regulates the kinase (38). Activated Met induces mitogenic,
motogenic, and morphogenic cellular responses (13$). In vivo, Met and
HGf/SF likely play a key role in regulating many aspects of embryonic
development including kidney and mammary gland formation (146-149),
migrationldevelopment of muscle and neuronal precursors (5$, 150) and liver
and placenta organogenesis (56, 57). HGF/SF-Met signaling also promotes
angiogenesis (151, 152) and has been described to facilitate wound healing
(153) and tissue regeneration (154). Met signaling ciearly has a role in normal
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cellular processes; this signaling pathway has also been implicated in tumor
development and progression. Met signaling can increase tumorigenicity,
induce celi motility, and enhance invasiveness in vitro and metastasis in vivo
(64, 65). In addition, Met signaling can increase the production of protease and
urokinase, which are associated with extracellular matrix/basal membrane
degradation and are important for metastasis (155). Activating MET mutations
leading to increased levels of tyrosine phosphorylation and enhanced kinase
activity toward an exogenous substrate when compared with wildtype MET
could contribute to papillary renal carcinoma and other human malignancies
(62, 75, 156-160). Particularly, Met activation via an autocrine HGF loop is
directly responsible for pseudopodial protrusion and ceil motility of turnor celis
(12$). Mutant MET induced motility of Madin-Darby canine kidney celis and
metastasis of NIH 3T3 celis while transgenic mice expressing the oncogenic
form of MET developed metastatic mammary carcinoma (6$).
Under physiological conditions, the Na’7H exchanger NHE1 extrudes one
ion in exchange for one extracellular Na ion. NHE1 is a ubiquitously expressed
membrane phosphoglycoprotein comprising 10-12 transmembrane segments
(N-terminal) and a large cytoplasmic tau (C-terminal). NHE1 is involved in
intracellular pH (pHi) homeostasis and cell volume regulation. An aikaline pHi
together with an acidic extracellular environment are associated with a
transformed or tumorigenic phenotype, suggesting that active proton extrusion
capabilities provide a twofold advantage to tumor ceils: the aikaline pi-li favors
metabolic processes associated with cellular proliferation, whereas the acidic
extracellular environment, a consequence of H extrusion, enhances the invasive
capacity of transformed ceils. The changes in pHi occuring during the migration
of peridontal ligaments ceils and human carcinoma and melanoma cells
implicate pHi modulation in ceil motility.
The MSV-MDCK-INV (INV) were selected from Moloney sarcoma virus
(MSV) transformants of the polarized epithelial MDCK ccli line for their
capacity to pass through a Matrigel®
—coated filter unit (161). INV ceils exhibit
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multiple pseudopodia, no visible actin stress fibers and 3-actin rich domains at
the tips of pseudopodia (161) where is concentrated the hepatocyte growth
factor receptor (HGF-R) otherwise lmown as the c-Met proto-oncogene (127).
Moreover, the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (129) and
the Na, H-exchanger NHE 1 (131) from ll\TV ceils were found to colocalize
with actin in pseudopodia, the site of dynamic actin polymcrization. We
hypothesized that AIP produced from glycolysis in pseudopodia would be
involved in modulating c-Met activation, motility and invasion of TNV cells.
We present here evidence of a pseudopodial ATP production by showing the
expression and enrichment of glycolytic enzymes (hexokinase, phosphoglucose
isomerase and aldolase) and the absence of mitochondrial proteins from I actin
rich pseudopodial domains. By using inhibitors of both the glycolytic and the
mitochondrial AI? production, we made the demonstration that the
pseudopodial ATP from glycolysis is essential for an adequate phosphorylation
and local activation of c-Met, which modulates for the most part the motile
character of INV celis. Furthermore, we show that NHE1 inhibition leads to a
reduction of c-Met activation involving local pHi homeostasis in celi motility
and invasion.
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2.3 Experimental Procedures
Autibodies and reagents
Antibodies to phosphotyrosine (PI), the glycolytic enzymes hexokinase-1
(HK), aldolase (ALDO), phosphoglucose isomerase (PGI) and the
mitochondrial pyruvate dehydrogenase kinase (PDK), the 20 kDa preprotein
transiocase of the outer membrane (TOM-20) were purchased from Santa Cruz
Bioteclrnologies, Inc (Santa Cruz, CA). Phospho-specific polyclonal c-Met (p-c
Met) antibodies were from BioSource International (Medicorp, Montreal,
Canada). Monoclonal antibodies to f3-actin, D-Iuciferin, luciferase firefly and 2-
deoxyglucose were purchased from Sigma Chemical (St.Louis, Montreal,
Canada). Antimycin-A (Anti-A; mixture ofthe components A1, A2, A3 and A.4),
oligomycin (Oligo; mixture of the components A, B and C) and iodoacetate
(IODO) were from Fluka Biochernika (Sigma division). fetal bovine serum
(FBS), glutamine, essential amino acids, vitamins, media, penicillin and
streptomycin were obtained from Tnvitrogen (Burlington, ON). Filters for
pseudopod purification were purchased from Becton Dickinson labware (B.F.K,
USA) and the ring from Boulons Plus (Anjou, QC). Texas Red-conjugated
phalloidin and secondary antibodies conjugated to either A1exa488, A1exa568 or
A1exa633 were obtained from Molecular Probes (Eugene,OR). ECL reagent
was from Mandel (St.-Laurent, Quebec).
Cet! Culture
M$V-MDCK-INV celis were cultured in Dulbecco’s minimum essential
medium containing 25 mM NaHCO3 (DMEM), 10% FBS, glutamine, 1%
essential amino acids, vitamins, penicillin, and streptomycin under 5% CO
atmosphere at 37 ° C. Celis were seeded and cultured for 48 h at 2.5 x ceils /
100 mm plate for imnntnobloting, at 4 x celis / 100 mm plate for ATP
measurements and at 2 x i0 ceils / 35 mm plate on glass coverslips for
immunolocalisation experiments.
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Drug treatments
MSV-MDCK-INV ceils were treated for 15 min (or longer, as indicated) with 3
x l0 M oligo, 6tg/mI anti-A, 2 mM IOA and 5.5 or 20 mM 2-DG in the
presence of high glucose (2smMglucose) or glucose ftee medium. In the latter,
medium was supplemented with 10 % dialysed FBS to avoid any glucose
source.
Pseudopods and Cet! bodies purjficatioit.
MSV-MDCK-INV pseudopods and ceil bodies were purified using a scaled-up
procedure (127) similar to that previously described (129). Briefly, MSV
MDCK-1NV celis were plated on 100 mm 1 trn pore filters rnounted between
two 3.5” custom-made washers in a 100 mm Falcon Petri dish and the exterior
sealed with agarose to prevent cell leakage to the bottom of the filter. Afier 24
hours culture, the filter was washed 4 times with cold PBS/CM and both sides
of the filter were scraped with a glass cover slip. Pseudopods (underside) and
celi bodies (upperside) were recovered from the cover slip in ice-cold lysis
buffer (lysis buffer consisting of cold PBS containing 1 % SDS, 5 mM EDIA,
0.2 mM orthovanadate, 40 mM j3-glycerophosphate and protease inhibitors
(ljig/ml aprotinin, 1ig/ml pepstatin, 1 jtg/ml leupeptin and 0.1 mM PM$F).
The recovered pseudopodia fraction (PPF) and cdl bodies (CB) were sonicated
twice for 15 seconds on ice, centrifuged for 20 minutes at 12,000 rpm, and the
supematant collected.
1mmuitoblot anatysis ofcet! tysates and PFF.
MSV-MDCK-INV celis were grown to 60-80% confluence on Petri dishes in
DMEM. Lysates for immunoblotting were prepared by adding 3X hot Laemmli
(95°C) or SDS lysis buffer directly to plates. for the SDS lysis buffer technique,
ccli monoiayers were washed at first three times with ice cold PBS/CM (140
mM NaCI, 2.7 mM MgCL2), harvested and centrifuged at low speed. Lysis
buffer consisting of cold PBS containing 1 % SDS, 5 mM EDTA, 0.2 mM
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orthovanadate, 40 mM 3-g1ycerophosphate and protease inhibitors (ljig/ml
aprotinin, 1 jig/ml pepstatin, 1 jig/ml leupeptin and 0.1 mM PMSF) . Cells were
lysed for 20 min on ice, and DNA was broken by sonication.
Protein content of celi lysates, purified pseudopodial fraction (PPf) and celi
bodies (CB) of MSV-MDCK-llJV ceils was determined using the BCA protein
assay (Pierce, Rockford, IL). Laemmli or SDS lysates, CB and PPF were
separated on 7.5 % or 12 % SDS-PAGE and transferred to Hybond C extra
nitrocellulose membranes. The labeled bands were revealed by
chemiluminescence ( ECL reagent) and exposed to Kodak biomax light film.
Intmunofluorescence tabeting.
Celis were cultured for 48 h on glass coverlips until confluent and subjected to
ATP depletion with or without a period of recovery. Ceils were fixed with 2 %
paraformaldehyde heated at 37°C for 15 min at room temperature and then
perrneabilized with 0.075 % saponin for 10 mm, or with methanol/acetone
(80%-20%) precooled at -80°C for 15 min at -20°C for F3—actin labelling.
After labeling, cover slips were mounted in gelvatol and were viewed with a
Zeiss Axioskop fluorescent microscope equipped with a 63X planapochrornat
objective and selective filters for fluorescein isothiocynate and Texas Red or
with the 60X Nikon planapochromat objective of a Bio-Rad Radiance 2000
confocal microscope.
Confocat imaging.
Images of all different fluorescence probes were obtained simultaneously using
a multichannel scanning procedure in which each une of the final image was
scaimed four times, using excitation and imaging filters specific for each
individual fluorophore.
54
Measurement ofA TP levet concentration.
ATP was extracted in 5 % TCA . Briefly, plates were scraped, keeped on ice
for 10 min then spun down at 4°C. Extracts were neutralized and ATP levels
were measured by bioluminescence in a 96 well plates using the Luciferine
Luciferase assay (70 mM Tris-Acetate, 4 mlvi EDTA, 0.125% bovine serum
albumin, 20 mM MgCL2, 0.7 mM luciferine and 20 i1 luciferase for each unit
of luciferin.
Motiity assay.
To measure ceil motility, 250 x i03 MSV-MDCK-INV celis were plated for 4$
h on glass coverslips until confluent and subjected to wound healing. Ceils were
treated for 3, 6 and 1$ hours with 3 .l0 M oligo, 6 tg/ml anti-A, 20 mM 2-DG
in the presence of glucose ftee medium supplemented with 10 % dialysed FBS
to avoid any glucose source. Ceils were fixed for 15 min with 2 %
paraformaldehyde rewarmed at 37°C at room temperature and coverslips were
viewed with 1 OX planapochromat objective.
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2.4 Resuits
Confocal imaging was used to determine if glycolytic enzymes colocalize with
13-actin and c-Met in protruding pseudopodia. Aldolase, hexokinase and PGI
colocalize with actin-rich pseudopodia and with p-c-Met (Figure 2.1). In
contrast, no colocalization was detected between the mitochondrial proteins
PDKI or TOM-20 with 13-actin (Figure 2.2). This implicates a ftmctional link
between pseudopodia-associated glycolysis, and phosphorylation of c-Met that
regulates celi motility and invasion ofMSV-MDCK-ll’JV celis.
The protrusive 13-actin-rich pseudopodia of TNV cells can be purified by plating
the celis on filters containing 1 im diameter pores for 24 hours which permit
the passage of celiular protrusions but not of the celi body and nucleus. The
isolated pseudopodial fraction (PPF) and cell body (CB) fraction were
compared to the total INV cdl lysate, and submitted to gel separation ami
immunoblotting (Figure 2.3). Hexokinase and PGI are present in MSV-MDCK
INV PPF although it is not concentrated in the PPF relative to ceil lysate and
CB. However, aldolase is cieariy accumulated in the pseudopod fraction. for
the same amount ofproteins, TOM-20 and PDK-l could not be detected in the
pseudopodial fraction even in blots exposed for longer time periods. (Figure
2.3) indicating their absence in that localized ccli membrane domain.
Glycolysis has been associated with cancer ceils and shown to be the primary
energy source for tumor cdl motility (134). Given the dernonstrated role of e-
Met phosphorylation in modulating cancer ccli motility (12$) and pseudopodiai
protrusion (12$), it was of interest to estimate the phosphorylation state of e-
Met under conditions where cell ATP concentration was rnodulated by the use
of different media and inhibitors. To demonstrate that glycolysis is required for
the actin remodelling and kinase phosphorylation, which both take place in the
pseudopod (127, 128), we incubated ll’JV celis in glucose free medium and
looked at the phosphorylation level of c-Met and actin labeling upon addition of
glucose, respectively as an indication ofthe ccli phosphorylative capacity and of
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its motile character (Figure 2.4). Glucose deprivation induced a lost of actin
rich protruding pseudopodia and apparition of stress fibers, effects which were
both reversed upon addition of a medium containing glucose (Figure 2.4A).
The phosphorylation level of c-Met (p-c-Met) was clearly increased upon
addition of glucose for 30 and 60 min (figure 2.4B). These resuits suggest that
glycolytic activity regulates the phosphorylation level of the tyrosine kinase c
Met receptor necessary to generate f3-actin concentrations at the tips of the
eÏongated pseudopodial projections.
The overali ATP concentration was then decreased by using 2-deoxyglucose (2-
DG) (Figure 2.4). 2-DG is a metabolic inhibitor that competes with glucose for
transport into the ceils, and once having entered ceils is phosphorylated by
hexokinase to 2-deoxyglucose-6-phosphate, which undergoes no further
metabolism. The consequence is a rapid decrease in cellular ATP concentration.
In the presence of 20 mM 2-DG, the f3-actin rich pseudopodial protrusions of
INV cells disappeared and extended lamellipodia formed (Figure 2.4A).
Peripheral actin bundles and stress fibers became apparent. It lias already been
shown that the disruptive effect of 2-DG on pseudopodial expression could be
prevented by the presence of glucose in the cell medium, either by adding 20
mlvi 2-DG to regular high glucose DMEM or by supplernenting 2-DG-
containing glucose free medium with 20 mM glucose (129). These results
further suggest that the glycolytic activity modulates the actin dyiiamics. The
addition of 5.5 or 20 mM 2-DG in the glucose free medium further decreases
the level of p-c-Met in the first minutes of addition then the p-c-Met signal
increases at the level observed in the absence of glucose (figure 2.4B). The
time-dependent increaement in c-Met phosphorylation and the disappearance of
stress fibers is interpreted as a stimulation of the mitochondrial synthesis of
ATP.
In order to further determine the importance of the glycolytic ATP production
on c-Met phosphorylation and on actin remodelling, we perforrned several
experiments intending to specifically decrease the concentration of ATP
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produced from glycolysis using the G3PDH inhibitor, iodoacetate (2mM), of
ATP produced from mitochondria using the ubiquinol-cytochrorne c oxidase
inhibitor antimycin A (6 j.tg/rnl) and the fo ATP synthase inhibitor oligomycin
(3J07 M) . Figure 2.5 confirms that the level of c-Met phosphorylation is
higher in high glucose medium compared to glucose-free medium. Iodoacetate
in high glucose medium decreases significantly the phosphorylation level of c
Met proportionaÏly to the decrease in the ATP concentration. However
iodoacetate has no effect on both p-cMet and the ATP concentration in the
absence of glucose.
In the presence of oligomycin and antimycin-A a 3 0-40 % decrease in ATP
concentration is observed in high glucose medium but is flot accornpanied with
a proportional decrease in p-c-Met level (Figure 2.5). In contrast, the important
decrease in the ATP level induced by these inhibitors in the absence of glucose
lcd to a major decrease in c-Met phosphorylation. These observations are in
accord with a specific role of ATP produced from glycolysis for c-Met tyrosine
phosphorylation.
In order to further demonstrate whether the glycolytic activity regulates the
association of glycolytic enzymes with actin-rich protrusive dornains, cells
treated with iodoacetate were labeÏÏed for actin and hexokinase (Figure 2.6).
Treatment with iodoacetate in high glucose medium resuits in a clear shortening
and broadening ofpseudopodia similar to that observed in low glucose medium.
Iodoacetate treated ENV ceils demonstrated that active glycolysis regulates the
formation of actin-rich protrusions and the association of glycolytic enzymes
with actin.
To assess whether ATP from mitochondrial respiration is also required for the
formation of —actin rich pseudopodia, ENV celis were incubated with
oligomycin or antimycin in high glucose and glucose-free media (Figure 2.7).
Treatment with oligomycin or antimycin in glucose-free medium compared to
treatments in the high glucose medium induced over time the Ïost of
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pseudopodia exhibiting 3—actin-rich densities, and ceils present multiple
membrane blebs (Figure 2.7a). Washout of these inhibitors and plating celis in
ftesh medium led to recovery within a 2-hour period of their protrusive
pseudopods indicating that oÏigomycin and antimycin-treated ceils are not
apoptotic (Figure 2.7b). Their ceil cytoskeletton is specifically destroyed.
Given the similar morphologic aspect of oligomycin and antimycin A-treated
ceils to TNV cells treated with EIPA (131), a specific inhibitor of the NHE1
isoform of the Na,H-exchanger (131), it was of great interest to investigate the
phosphorylation level of c-Met in the presence of an inhibited NHE1. Celis
were treated for 30 min to 3 hours with DM$O and 50 .iM EIPA, a dose shown
to be necessary to decrease by 80 % the specific 22Na uptake in those celis
(131). As above, celi lysates offNV were immunoblotted for p-c-Met. Figure $
shows that treatment with EIPA induces a rapid and significant decrease in the
c-Met tyrosine phosphorylation level of fNV ceils compared to DMSO- treated
ceils. These resuits are indicative of a functional link between the EIPA-induced
intracellular acidification (131) and the phosphorylation level of c-Met, a
tyrosine kinase receptor. The important ceil acidification upon NHE1 inhibition
being around 0.7 pH unit may inhibit by feedback the hexokinase enzyme
activity and lead to decreased ATP production (162), which regulates the
phosphorylation level of the tyrosine kinase c-Met receptor (Figure 2.8). Such
that localisation of NHE1 in turnor cell pseudopodia may be specifically
involved in regulating pHi in these regions of high glycolytic activity. NHE Ï
accurnulates with -actin at the tips of ceil pseudopodia, its inhibition with
EIPA induces significant intracellular acidification, which prevents
pseudopodial protrusions and inhibits MSV-MDCK-INV celi motility. These
resuits implicate NHE1 in the acquisition of motile and invasive properties by
TNV celis.
To determine that the glycolytic ATP production within pseudopodia of ENV
celis is necessary to drive ceil rnotility, wound-healing assays were realized to
estimate the motile capability of ENV cells in conditions shown to modulate c
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Met phosphorylation level. 111e motile character of TNV celis through the
wound can be observed afler 6 hours in high glucose and in glucose-free
medium (Figure 2.9). The treatment with 2-DG inhibits the motility but its
effect decreased over the time. This is consistent with the above observation
(figure 3b) where a rapid decrease in p-c-Met level was observed upon
addition of 2-DG followed by a time-dependent p-c-Met recovery. Treatment
with oligomycin and antimycin in high glucose medium lias no effect on
motility whereas these mitochondrial inhibitors nearly abolished the motile
character of INV cells in the absence of glucose. The delayed inhibition of
motility induced by oligomycin and antimycin in glucose-ftee medium as
compared to 2-DG is consistent with the more immediate disruption of f3-actin-
rich pseudopodia by 2-DG than by oligomycin and antimycin. Wound healing
assay on INV cells thus unraveals their glycolytic ATP-dependent motile
phenotype.
60
2.5 Discussion
A metabolic imbalance exists in progressively malignant tumor ceils. The
observation that rapidly growing tumor celis have a higli aerobic glycolysis was
first reported by Warburg (69), who considered that eievated glycolysis was a
consequence of an impairement in the respiratory rnechanism of celis caused by
carcinogens. Warburg noted that in ail of the tumors he examined respiration
was low and glycoiysïs was high.
The MSV-MDCK-1NV celi une was seiected from Moloney sarcoma virus
transformed epithelial MDCK ceils for their enhanced invasive ability (161).
Sequencing of a 37 kDa protein in their pseudopodia had identified this protein
as GAPDH, a criticai enzyme in the process of glycoiysis (129). In the present
study we were interested in investigating the mechanism underlying the criticai
roie of giycoiysis in tumor celi motility, which is to drive the formation and
protrusion of turnor celi pseudopodia.
MSV-MDCK-INV ceils were isoiated by their enhanced capacity to traverse
Matrigel-coated fiiters and exhibit multiple 13-actin-rich pseudopodia (127, 129).
We took advantages of the improved pseudopod purification technique which
gives hundred of tg of pseudopodial proteins to determine the content in
giycoïysis enzymes (hexokinase, aldoiase, phosphoglucose isomerase) and
mitochondriai proteins (PDK-1 and TOM 20) relative to 3-actin and p-c-Met in
ceil bodies and total celi lysates. Actin-labeled ceil bodies couid be visualized
on the upper surface of the fiiter. The 1 jim size-filter pores therefore prevent
passage of the ccli body but permit passage of actin-rich protnisions (127, 129).
This allowed us to show that glycoiytic enzymes are present or enriched in
MSV-MDCK-INV pseudopodia relative to INV total celi iysate and that
mitochondriai proteins are absent from the pseudopodial fraction indicating that
pseudopodia are devoided ofmitochondria.
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The concentration of f3-actin in the isolated pseudopodia of fl\TV ceils as
demonstrated by immunoblot and immunolocalisation (161) provided the first
biochernical evidence that -actin concentrates in motile cellular regions.
Association of glycolytic enzymes with the actin cytoskeleton is well
documented and implicated in the regulation of actin cytoskeleton dynarnics and
glycolytic activity (131). Interaction between actin and glycolytic enzymes may
therefore provide an immediate and localized energy supply for the active
assembly and desassembly of actin filaments which drives pseudopodiai
protrusions.
The selective increased phosphorylation of HGF-R in the invasive variant,
MSV-MDCK-INV celis, but not in the parental MSV-transformed MDCK
celi population (128) is highly consistent with the enhanced phosphorylation
of HGf-R in metastatic tumor celïs (163, 164). It further illustrates that
constitutive phosphorylation of HGfc-Met is associated flot with
transformation but with the acquisition of motile and invasive properties by a
variant of this transformed epithelial MDCK cell une (12$). There are
several factors that can contribute to the avaiiabiiity of the ce!!
phosphorylating system and to the control of ceil energy states in the ceil.
Glycolysis was found, in the present study, to be the main source of ATP
required to phosphorylate the kinase domain of c-Met-dependent receptor
signalling and activate its biological function.
Inhibiting glycolysis with iodoacetate or clearing available ATP with 2-DG
reduces the cellular ATP concentration and disrupts the hexokinase
accumulation in the actin-rich domains with clear morphological changes
transforming the elongated pseudopodia to actin bundies and appearing of
stress fibers. Furtherrnore it will decrease the phosphorylation of the tyrosine
kinase residues of c-Met and will slow down its signaling pathways. Ail of
the above events wiÏÏ resuit in the clear interuption of the motile character of
INV celis.
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Having specified that mitochondria are absent from protruding pseudopodia and
that glycolysis enzymes are present, it is thinkable that protons are locally
produced from anaerobic glycolysis. Thus, anaerobic glycolysis conversion of
one mole of glucose to two moles of pyruvate then to lactate is accompanied by
the net production of two moles of ATP, 2 NADH and 2 protons. To avoid ceil
acidification, celis have evolved many systems to regulate intracellular pH.
Perhaps the best characterized are the Na-H exchangers (NHEs) (105, 165, 166)
and the anion exchangers chlore-bicarbonate (AEs).
Studies have recently examined the Na/H exchanger in several models of
human tumors. They suggest that, in at least some celi types, the Na/H
exchanger and intracellular pH regulation associated with this protein play an
important role in tumor celi growth. Early studies showed that the Na7H
exchanger deficient celis (101) cannot proliferate in HC03 free media of low
external pH and lost or severely reduced their capacity to grow tumors in vivo in
immune deficient mice. In addition, several evidence have suggested that
activation of the Na/H exchanger and the resultant increase in intracellular pH
may be required for proliferation in some ccli types (107)
Because of the important role of the Na/H exchanger in tumor and celi
growth, amiloride and its analogues have been extensively tested for use in
tumor selective therapy (100, 122, 167-173). The large amount of protons
generated by the pseudopodial glycolysis would be extruded from the ce!!
through the Na/H exchanger found locally within the pseudopodia. We have
previously shown that the INV cells present a proton-dependant 22Na uptake
sensitive to EIPA, identified with specific antibodies as the isoform 1 (NHE 1)
(131). NHE1 is localized to the pseudopodia ofTNV celis, where it colocalizes
with f3-actin (131). Pseudopodial protrusion is an essential aspect of ceil
motility (12$) and the inhibition of pseudopodial protrusion with the NHEÏ
inhibitor EIPA identifies a necessary role for NHE1 in the regulation of the
actin cytoskeleton dynamics that regulate pseudopodial protrusion and ceil
rnotility (131). We have hypothesized that the large amount of protons
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generated by the pseudopodial glycolysis would be extruded from the celi
pseudopodia through the Nat’H exchanger found locally within the
pseudopodia, so the inhibition of proton secretion with EIPA will increase the
H concentration inside the ceil, which will affect through retro-inhibition the
glycolytic ATP production. Once reduced this ATP will not be enough to
respond for the high demand of energy required for the motility processes of
TNV celis.
The demonstrated association of glycolytic enzymes, and not mitochondria with
TNV pseudopodia, the colocalization with c-Met and NHE 1, the ability of 2-DG,
EIPA and iodoacetate to disrupt the formation of —actin-rich pseudopodia and
decrease the phosphorylation level of c-Met implicate a functional link between
actin, c-Met, NHE1 and glycolytic enzymes. We interprete these resuits as the
localized pseudopodial glycolytic supply of energy is necessary to celi motility
and invasion ofMSV-MDCK-INV celis through activation of c-Met by tyrosine
phosphorylation.
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Figure legends
Figure 2.1
(o1ocatization ofgtycotytic enzymes wit!t p-c-Met in fi -actin rie!, psendopodia
of MSV-MDCK-INV cetts. MSV-MDCK-INV ceils were fixed with 4 ¾
paraformaldehyde and irnmunofluorescently Iabeled for hexokinase, aldolase,
and phosphoglucose isomerase. Alexa 488 conjugated to anti-goat antibodies
(HK, ALDO), alexa 588 conjugated to anti-mouse antibody (13-actin) and alexa
647 conjugated to anti-rabbit antibodies (p-c-Met, and PGI) were used.
Confocal images from ail fluorescent chaimels were superimposed and
colocalization (merged images) appears in yellow (green and red) or white
(green, red and blue).
Figure 2.2
Pseudopodia of MSY-MDCK-INV cetts are divoided front Mitochondriat
proteins . MSV-MDCK-fNV were fixed with methanol/acetone ($0/20) and
immunofluorescently labeled with antibody directed against TOM2O, PDKY,
and 13—actin. The following secondary antibodies were used: Alexa 488
conjugated to anti-goat antibodies (PDK1), alexa 48$ conjugated to anti rabbit
antibody (TOM2O), alexa 588 conjugated to anti-mouse antibody (13-actin).
Determination of the cellular distribution of mitochondrial proteins by
immunofluorescent labeling confirrned the absence of mitochondrial proteins
from the pseudopodia of MSV-MDCK-INV celis.
Figure 2.3
Gtycotytic enzymes are present or concentrated ut pseudopodiat fraction, and
mitochondriatproteins are abseitt. Glycolytic enzymes (HK, ALDO, and PGI),
mitochondrial proteins (TOM-20 and PDK1), 3-actin and p-c-Met expression
were studied by immunoblot in fractionated MSV-MDCK-INV celis. Total celi
lysates of INV, PPf and CB were isolated as described in Methods and were
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blotted with the corresponding antibody on fresh nitroceilulose membranes.
Hexokinase, PGI and aldolase are present in MSV-MDCK-1NV PPf, CB and
celi lysates and colocalize with p-c-Met and 3-actin. For the same arnount of
proteins, TOM 20 and PDK-1 could flot be detected in the pseudopodial fraction
even in blots exposed for longer time periods. These blots were ail obtained on
the same preparation.
Figure 2.4
Glycotytic activity regtttates ti’te actin dynamics aitd the pliosphoiytation tevet
of c-Met. NV cells incubated in glucose free medium were freated with 5.5 or
20 mM of glucose (30’ and 60’) and with 5.5 or 20 mM 2-DG (30’ and 60’),
then A) either immediately fixed for rhodamin conjugated phalloidin labeling or
B) ice-cold stopped for c-Met phosphorylation determination; CelI lysates were
prepared and blotted as described with p-c-Met antibody. Cells incubated in
glucose-ftee medium (A), supplemented with 20 mM glucose for 30 min or 60
min retained 3-actin concentrations at the tips of elongated pseudopodial
projections. In the presence of 20 mM 2-DG for 30 or 60 min , the f3-actin rich
pseudopodial protmsions of TNV cells disappeared and extended lamellipodia
fomed. Peripheral actin bundles and stress fibers became apparent, and
correlated with the decrease in c-Met tyrosine phosphorylation.
Figure 2.5
Phospltoiytation degree of c-Met is higiter iii Itigh glucose inediain compared
to ii gÏucose-free one. MSV-MDCK-ÏNV cells were treated for 15 min with 3 x
1 0 M oligornycin (oligo), 6-.tg/ml antimycin-A (Anti), and 2 mM iodoacetate
(IOA) in the presence ofhigh glucose medium (25 mM glucose) or glucose free
medium. The low glucose medium was supplernented with 10 % dialysed FBS
to avoid any glucose source. Ice-cold ceils were lysed in lysis buffer
immediately after treatments and deproteinized in 5 % trichloroacetic acid for
ATP determination by luminescence or lysates blotted for p-c-Met and
phosphorylation level was quantified.
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Figure 2.6
Treatntent with iodoacetate in high glucose inedium resutts in a ctear
shortening and broadening of pseudopodia simitar to that observed in low
glucose ntediuin. Ceils were fixed immediately afier treatment with warm
paraformaldehyde to determine the consequences on actin cytoskeleton and
hexokinase celi distribution following iodoacetate treatment in high glucose
medium compared to glucose-free one.
Figure 2.7
Treatments with otigomycin or antimycin in gtucose—free coinpared to high
glucose medium induced the loss ofpseudopodia, and appearance 0f multtote
membrane blebs. The disappearance of t3-actin-rich pseudopodial protrusions of
INV ceils in glucose-free medium treated ceils (A) indicates that glycolytic
ATP is important for the maintenance and the dynamic remodelling of actin
during invasion. Celis washed from oligomycin and antimycine (B) and plated
in fresh medium recovered with time their protrusive pseudopod indicating that
oligomycin and antimycin-treated celis are flot apoptotic.
Figure 2.8
Iiih ibition of Na+, H+_excllange activity decreases c-Met phosphoiylation.
MSV-MDCK-INV cells were incubated in a high glucose medium containing
no NaHCO3 but 50 jiM EIPA for 5’, 30’, 60’ and 180’ at 37 C or DM$O in
HEPES medium for 15’ and 180’. Control celis were let in their original
medium for another 180’. Inhibition of NHE1 by EIPA induces a pronounced
decrease in INV c-Met tyrosine phosphorylation level.
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Figure 2.9
Tite wound healing linked to the motite character ofINV cetts is significantty
decreased in tue absence ofglucose. The migratory rate ofMDCK-MSV-NV
celîs in a wounding assay was determined by measuring wound width as
function oftime for ceils plated on gridded coverslips. Data are expressed as the
mean (SEM) of three experiments.Wound assays of ll’JV celis in high glucose
medium alone (30’ and 6h) or supplemented with 3 .1 0 M oligo; 6 jig/ml anti-
A compared with NV celis in glucose-free medium alone (30’ and 6h) or
supplernented with 3 .10 M oligo; 6 jtg/ml anti-A; 20 mM 2-DG.
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CHAPTER 3
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3.1 Study overview
A high rate of proliferation is characteristic of malignant tumor celis. This by
itself does flot account however for the ability of the celis to leave the primary
tumor mass and metastasize to secondary sites. Tumor ceils from the primary
mass must aggressively migrate through stromal matrix and vessel walls
following the metastatic process (174, 175).
The MSV-MDCK-TNV ceil une was selected ftom Moloney sarcoma virus
transformed epithelial MDCK celis for their enhanced invasive ability and
exhibits multiple f3-actin-rich pseudopodia (161). The MSV-MDCK-INV ceils
migrate in response to self-generated autocrine motility factor (129) and
hepatocyte growth factor in a receptor-mediated process (12$). HGF stimulates
chemotaxis and may play a role in the homing of invasive cells to secondary
sites (174, 175).
In the present study we were interested in investigating the mechanism
underlying the critical role of glycolysis in tumor ceil motility, which is to drive
the formation and protrusion oftumor cell pseudopodia.
3.2 Biochemical charactcrïzation oftumor ccli pseudopodia
Malignant cells are known to exhibit a high rate of glycolysis even under
aerobic conditions (69). Glucose utilization through glycolysis, which is the
primary energy source in cancer ceils, is known to be controlled by allosteric
regulators, as well as by reversible binding of glycotytic enzymes to
cytoskeleton enabling the compartmentalization of these energy-generating
enzymes to specific cytosolic locations. Sequencing of a 37-kDa protein in the
MSV-MDCK-TNV cells pseudopodia had identffied this protein as GAPDH, a
critical enzyme in the process of glycolysis (129). GAPDH is present in
pseudopodial protrusions, its expression in these regions is reduced compared to
the rest of the cell (129). GAPDH is therefore not concentrated in MSV
MDCK-ll’JV pseudopodia. However, the fact that this protein is detected by the
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Coomassie blue staining within the pseudopodial fraction identifies it as one of
the major proteins present within pseudopodia and is indicative of a ftinctional
role for this protein in pseudopodial protrusion (129).
We took advantages of the improved pseudopod purification technique
developed by Zongjian Jia from the Nabi’s laboratory which gives hundred of
ig of pseudopodial proteins to determine the content in glycolytic enzymes
(hexokinase, aldolase, phosphoglucose isomerase) and mitochondrial proteins
(PDK-1 and TOM 20) relative to 13-actin and p-c-Met in cell bodies and total
cell lysates. The 1 t size-filter pores prevent passage of the ceil body but
permit passage of actin-rich protrusions (129, 176). Parrallele imniunoblots of
the PPF, CB and ccli lysates revealed that hexokinase and PGI are present in
INV PPF although it is flot concentrated in the PPF relative to ceil lysate and
CB (Figure 2.3), as was previousiy observed for GAPDH. However, aldolase,
the fourth enzyme in the glycolysis cascade, is clearly accumulated in the
pseudopod fraction compared to the 1NV cell lysate or ccli body fraction.
These results confirm Sibley and Lehninger’s (1948) observations, who
extended the studies to human cancer, and Warburg and Christian’s (1943)
observations who conceived the possibility that the biood leaving the tumor
and entering the generai circulation might show elevation of serum glycoiytic
enzymes. Indeed, they found that serum aldolase activity was elevated in rats
bearing the Jensen sarcoma. By contrast, the fact that in our model the two
mitochondrial proteins, TOM-20 and PDK- 1, could not be detected in the
pseudopodial fraction (Figure 2.3) indicates an extremely low amount of
these proteins or their absence in that locaiized cdl membrane domain. These
results are also indicative of a very good purification process for the
pseudopodia. Considering the large amount of mitochondrial PDK-1 and
TOM-20 proteins into the cytoplasm, the ciear distribution of glycolytic
enzymes and mitochondrial proteins respectively in and out of pseudopodia
reflects a quite pure pseudopodial fraction.
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f3-actin is flot as concentrated as should be expected from the clear
pseudopodial t3-actin accumulation observed upon immunolocalisation (128,
161). The lack of a net accumulation of 3-actin within the pseudopodial
fraction led us to compare these three fractions. We first thought that for the
same amount of proteins (50 tg) loaded onto the gel, a protein which is
abundantly expressed within the pseudopodia, as is the case for 13-actin,
should be highly enriched in PPF as compared to CB fraction. However, only
a 1.5 to 2.5 enrichment factor is repeatedly found. A possible explanation for
this observation is that a comparable amount of proteins is present within the
pseudopodial fraction (regrouping 2-6 pseudopodia per celi) and within the
celi body fraction, given that the pseudopodia are a very well developed cell
domain. An enrichment factor of 1,5-3 for f3-actin in PPF compared to INV
cell lysate would then be normal. BSA protein may present another
explanation if BSA protein present in the culture medium contaminates
proportionnaly more PPF than CB or LNV lysates. This however does not
seem to be the case since a Ponceau coloration of the three fractions does flot
reveal a major band corresponding to 68 kDa, the molecular weight of
albumin. Our results are clear and indicate a very good pseudopodia
purification, but there is a need for a better quantification process.
Quantification of phospholipids seems to be problematic since the dosage is
very sensitive to the presence of phosphate; the fact that TNV celis need to be
washed with a phosphate-containing buffer avoids us the use of this technique
to quantitate the respective fractions. Quantification of cholesterol could be
another method. However, for the moment, we estimate that this technique
will not be optimal neither. Indeed, the fact that mitochondria lack cholesterol
will avoid them to be quantified in the total cdl lysates, increasing falsely the
enrichrnent factors of accumulated pseudopodial proteins. This technique
would nevertheless ment to be explored.
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3.3 3-actin rich tumor celi pseudopodia: Role of glycolysis
Association of glycolytic enzymes with the actin cytoskeleton is well
documented and implicated in the regulation of actin cytoskeleton dynamics and
glycolytic activity (136). In vivo glyceraldehyde-3 -phosphate dehydrogenase
has been shown to be associated with F-actin in synaptosomes and at post
synaptic sites (137) Moreover, it has recently been localized to the actin-rich
pseudopodia of MSV-MDCK-INV cells (129). In very confluent cultures of
epithelial MDCK cells, glyceraldehyde-3-phosphate dehydrogenase was triton
X-100 insoluble and exhibited ATP-dependent cytoskeleton association.
Immunolocalization of hexokinase, aldolase and phospho-glucose isomerase to
actin rich domains of MSV-MDCK-fl’W ceils therefore identifies other
glycolytic enzymes that are associated with actin-rich pseudopodia and suggests
that multiple glycolytic enzymes are expected to be associated with motile
actin-rich pseudopodial dornains.
For the tumor ceil, up regulation of multiple glycolytic enzymes is associated
with tumor malignancy (133) and glycolysis is the principal supply of energy
for cell motility (129) . Glycolysis was indeed shown to regulate the protmsion
of the multiple pseudopodia, and thereby the motility of MSV-MDCK-ll1V
cells (129)
. Localized actin polymerization responsible for the protTusion of
motility-associated cellular structures is a critical element of cell movement.
Interaction between actin and glycolytic enzymes may therefore provide an
immediate and localized energy supply for the active assernbly and desassembly
ofactin filaments which drive pseudopodial protrusions (129).
Glycolytic activity correlates with cell cycle associated changes in the F-actin
cytoskeleton suggesting that glycolytic activity may regulate actin cytoskeleton
organization (129). The ability to disrupt the interaction of hexokinase with the
actin cytoskeleton by using 2-deoxyglucose (figure 2.4) demonstrates that the
local concentration of ATP can regulate the association of glycolytic enzymes
with the actin cytoskeleton. Formation of a localized glycolytic cytomatrix at
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the site of pseudopodial protrusion is therefore invoived in active actin
mediated pseudopodiai protrusion. Increased expression of glycolytic enzymes
in tumor celis may act to enhance tumor maiignancy in two ways: 1) by
enhancing glycolytic activity and stimulating pseudopodial activity. 2) via the
phosphorylation and activation of the hepatocyte growth factor receptor, c-Met,
which drives pseudopodial protrusion and motiiity (12$).
3.4 Phosphorylated c-Met induces tumor ccli motiiity by regulating
pseudopodial protrusion.
Induction of severai biologicai activities critical for deveiopment and
maintenance of normal ceilular functions such as proliferation, motility,
survivai, and differentiation are mediated by protein growth factors and their
associated receptor tyrosine kinases. The c-Met receptor tyrosine kinase is a
member of a smaii subfamiiy of growth factor receptors that when activated
induces mitogenic, and morphogenic cellular responses. The ligand for Met is
hepatocyte growth factor/scatter factor (HGF) and whiie normal HGf/Sf-Met
signaling is required for embryonic development, abnormal Met signaling has
been strongiy implicated in tumorigenesis, particulariy in the deveiopment of
invasive and metastatic phenotypes. foilowing ligand binding and
autophosphorylation, Met transmits intraceliular signais using a unique muiti
substrate docking site present within the C-terminal end ofthe receptor (13$).
While the importance of the multidocking site in Met-mediated proliferation,
ceil rnovement/invasion, and branching morphogenesis has been appreciated
for severai years, oniy recentiy have more complete modeis been developed
for how this site organizes a signaling complex following UGf!stirnulation
(13$). Disruption of the signaling complex by either inhibiting the ATP
production (this study and (129) or blocking the Nat’H exchanger (177)
ieads to loss ofceil pseudopodia (Figure 2.6; 2.7; 2.8).
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Clarification of the metabolic events involved in tumor celi motility could
lead to improvements in therapy and diagnostic tests for aggressive
malignancies with metastatic potential. There are several factors that can
contribute to the availability of the ccli phosphorylating system and to the
control of ceil energy. Glycolysis was found, in the present study, to be the
main source of ATP required to phosphorylate the kinase domain of c-Met,
due probably to the localized expression of c-Met within the pseudopodia
(Figure 2.4). Once ATP binds to its site, the receptor will autophosphorylate
the tyrosine residues in position 1230, 1234, 1235 of the human c-Met
tyrosine kinase domain, then induces phosphorylation of tyrosine in position
1349 and 1365 of the multidocking site to activate its biologicai functions
(145). Pseudopodial glycolysis appears to play a critical role in activating
signal complexes, flot only by phosphorylating the tyrosine residue of c-Met,
but also by recruiting the ATP for the actin remodeling.
Signals that derive from c-Met activation to the extraceliular matrix (ECM)
regulate important physiological events including ceil rnotiiity and growth,
and most oflen involve changes in the organization of the actin cytoskeleton
(138). Cells interact with the ECM via different signal transduction
pathways, and signaling molecules to the sites of matrix provide links to the
actin cytoskeleton. Our results suggest that glycolysis first affects c-Met
activation, then the regulation of the actin cytoskeletai dynamics. The HGF
dependent phosphorylation of c-Met on its tyrosine kinase residues elicits the
generation of pseudopodia (128) . Inhibition of glycolysis propagates the
formation of actin stress fibers and loss of 3-actin rich-elongated
pseudopodia (129).
3.5 Glycolysis as primary energy source in tumor ccli chemotaxis
Tyrosine phosphorylation is generally associated with cellular transformation
and increased cellular motility of tumor cells More specifically, tyrosine
phosphorylation of c-Met was shown to regulate the formation of the -actin
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rich pseudopodia of ENV ceils (12$). In order to determine the importance of
the glycolytic ATP production on c-Met phosphorylation and on actin
remodelling, we performed several experiments intending to specifically
decrease the concentration of ATP produced from glycolysis by the G3PDH
inhibitor iodoacetate ATP produced from mitochondria by the ubiquinol
cytochrome e oxidase inhibitor antimycin A and the Fo ATP synthase
inhibitor oligomycin.
A critical role for glycolysis-dependent tyrosine phosphorylation in the
acquisition of the motile phenotype of ENV ceils was determined using the
G3PDH inhibitor, iodoacetate , and the tyrosine phosphorylation level in
position 1230, 1234 and 1235 ofthe tyrosine kinase receptor c-Met. Tyrosine
phosphorylation of the 160 kDa protein identified as c-Met decreased
significantly on iodoacetate treatment (Figure 2.5). Treatment of MSV
MDCK-1NV ceils with iodoacetate resulted in a graduai disappearance of the
3-actin rich pseudopodia. A glycolysis ATP production coupled to the
activity of cellular tyrosine kinases is therefore required for pseudopodial
protrusion found in MSV-MDCK-TNV celis, supporting a role for HGF-R!c
Met tyrosine phosphorylation in this process.
Figure 2.5 confirms that the level of c-Met phosphorylation is higher in the
high glucose medium compared to the glucose-free one. Iodoacetate in high
glucose medium decreases significantly the phosphorylation level of c-Met
proportionally to the decrease in the ATP concentration. However iodoacetate
has no effect on both p-c-Met and the ATP concentration in the absence of
glucose, thus ruling out a non-specific effect of iodoacetate on these parameters.
While the glycolytic activity is an important source of energy in cancer ceils,
the mitochondrial oxidative phosphorylation is also a major site of ATP
production. The 3 0-40 % decrease in the ATP concentration observed with
oligomycin and antimycin A in high glucose medium is not accompanied with a
proportional decrease in p-c-Met level (Figure 2.5). In contrast, the important
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decrease in the ATP level induced by these inhibitors in the absence of glucose
lcd to a major decrease in c-Met phosphorylation. These observations are in
accord with a specific and major role of ATP produced from glycolysis for c
Met tyrosine phosphorylation.
We characterized the energy metabolism in proliferating 1NV cells using
inhibitors of both glycolysis and mitochondrial respiration, and we determined
the relative contributions of these pathways to motility. Inhibiting glycolysis
with iodoacetate reduces the cellular ATP concentration and results in a clear
shortening and broadening of pseudopodia similar to that observed in low
glucose medium. Iodoacetate treated INV celis demonstrated that active
glycolysis regulates the formation of actin-rich protrusions and the association
ofglycolytic enzymes with actin (Figure 2.6).
To assess whether ATP from mitochondrial respiration is also required for the
formation of 3—actin rich pseudopodia, INV cells were incubated with
oligomycin or antimycin A in high glucose and glucose-free media (figure
2.7). Treatments with oligomycin or antimycin in glucose-free medium
compared to treatments in the high glucose medium induced over time the lost
of pseudopodia exhibiting 13—actin-rich densities, and cells present multiple
membrane bÏebs (Figure 2.7a). Celis washed from these inhibitors and plated in
fresh medium recovered within a 2-hour period their protrusive pseudopods
indicating that oligomycin and antimycin-treated cells are flot apoptotic (Figure
2.7b). Their ccli cytoskeletton is specifically destroyed.
3.6 Ceil migration requires both ion transiocation and cytoskeletal
anchoring by the Na-H exchanger.
Studies have examined the roles of Na/H exchanger in several models of
human tumors (101). They suggest that, in at least some cdl types, the Na/H
exchanger and intracellular pH regulation associated with this protein play an
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important role in tumor ceil growth. Early studies showed that the Na’7H
exchanger deficient celis cannot proliferate in HC03 free media of Iow external
pH and lost or severely reduced their capacity to grow tumors in vivo in immune
deficient mice (101). A lot of observations have suggested that activation of the
Na/H exchanger and the resultant increases in intracellular pH may be
required for proliferation in some ccli types (107).
Because of the important role of the Na’7H exchanger in tumor celi growth,
arniloride and its analogues have been extensively tested for use in tumor
selective therapy (100, 122, 167-173). Pseudopodial protrusion is an essential
aspect of ceil motility (128) and the inhibition of pseudopodial protrusion with
the NHE1 inhibitor EIPA identifies a necessary role for NHE1 in the regulation
of the actin cytoskeleton dynamics that regulate pseudopodial protrusion and
celi motility (131). NHE 1 is iocalized to the pseudopodia of TNV ceils, where it
colocalizes with f3-actin (131) and where are also localized four enzymes of the
glycolytic pathway (Figure 2.3).
Having specified that glycolysis enzymes are present within protruding
pseudopodia, that mitochondria are absent, and having indirectly demonstrated
that a significant glycolytic activity takes place within pseudopodia, it was
expected that protons would be locally produced from glycolysis. We have
hypothesized that the large amount of protons generated by the pseudopodial
glycolysis would be extruded from the pseudopodia through the Na7H
exchanger, so the inhibition of proton secretion by EIPA would increase the H
concentration inside the ccii, and significantly more within the specialized
pseudopod membrane compartment, which would affect through retro
inhibition the glycolytic ATP production. Once reduced this ATP might not be
in sufficient concentration to respond for the high demand of energy required
for the motility processes of INV cells.
The decrease in the phosphorylation level of c-Met (Figure 2.8) upon EIPA
treatment may be a consequence of the reduced glycolytic metaboiism and
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suggests an essential role for NHEI to secrete protons generated from
glycolysis, to regulate the phosphorylation level of the tyrosine kinase c-Met
receptor and to retain the 3-actin concentration at the tips of elongated
pseudopodial projections. A more direct effect of ceil acidification on tyrosine
kinase activity of c-Met should also be envisaged.
3.7 Glycolysis and tumor ccli motility.
The increased phosphorylation level of INV c-Met compared to MDCK c-Met
is relative to the enhanced phosphorylation of c-Met in metastatic tumor celis
(128). Further it makes the link between the phosphorylation of this tyrosine
kinase receptor and the acquisition of the motile character of TNV ceils.
Localization to the plasma membrane of constitutively activated Met oncogene
with a c-Src myristoylation signal induces enhanced MDCK ceil transformation
as well as pseudopodial protmsions (178). Similarly, constitutive localized
activation of the HGF-RJMet tyrosine kinase may be responsible for the rapid
pseudopod formation ofthe MSV-MDCK-ll\JV variant and acquisition ofmotile
and invasive capabilities (128).
INV cells are highly invasive as shown by their ability to migrate through a
collagene-coated filter (Y. Dodier, J. Noêl and collaborators, in preparation). In
the latter study, it was shown that both the Pl3kinase and the MEK-ERK
pathway are involved in directing the invasive character of INV cells (179) The
cellular mechanisms underlying their motile behavior are further clarified in the
present study by the demonstration of energy mobilization via glycolysis and
mitochondria, with glycolysis favored as the major pathway for in vitro
motility. The energy requirements via glycolytic pathways were directly
demonstrated in migrating INV cells (Figure 2.9). The motile character of INV
cells through the wound can be appreciated after 6 hours in high glucose and in
glucose-free media. Treatment with oligomycin and antimycin in high glucose
medium has no effect on motility whereas these mitochondrial inhibitors nearÏy
abolished the motile character of NV ceils in the absence of glucose. In
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glucose-free conditions, HGf-dependent rnotiÏity was dependent on
mitochondria-derived energy and represented only a fraction of what could be
achieved in the presence of glucose. Thus, our resuits clearly showed that
motility of the invasive MDCK celi line, the M$V-MDCK-TNV celis, depends
on pseudopodial glycolysis in the presence of glucose as its principal source of
energy.
3.8 Conclusions and perspectives
The major purpose of our research was to understand the link between the
pseudopodial -actin, glycolytic enzymes, c-Met and NHE1 in regulating ceil
motility. Localized actin polymerization drives the protrusion of motility
associated cellular structures, and pseudopodial protrusion is a critical element
of cell movement (180). Glycolytic enzymes had been localized to the actin-rich
pseudopodia of an invasive variant of Moloney sarcoma virus-transformed
MDCK celis and glycolysis shown to regulate the protrusion of the multiple
pseudopodia, and thereby the motility, of those cells (129) Our hypothesis
suggests that to avoid any intracellular acidification by protons produced ftom
the glucose metabolism, protons would be directly extruded via the local
membrane Na/H exchanger NHE1 and ATP produced from glycolysis would
serve to polymerize the actin monomers and also, to phosphorylate the HGF
receptor (Figure 3.1). As EIPA was shown to inhibit the Na/H exchanger
activity and induce a significant intracellular acidification (RI), we propose
that the high intracellular H concentration would affect the glycolytic pathway
and decrease the ATP production, necessary to phosphorylate c-Met and other
components of the signalling machinery such as Pl3kinase, Akt, MEK, ERK
etc. As these pathways are implicated in activating the motogenic pathway,
through modulation of the remodelling of actin, an intracellular acidification
would also perturb the protrusion ofpseudopodia, as previously observed (131).
The Na/H exchanger NHE1 localized close to the site of ATP production
within the pseudopodia would be there to insure the continuous secretion of
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protons produced locally by the glycolysis pathway, and to avoid feedback
inhibition ofhexokinase by accumulated protons.
Recent findings on this colocalization will lead to exciting new areas for future
investigations. findings that pseudopodial glycolytic enzymes and NHE1
activities contribute to migratory responses indicated the need for glycolytic
flux measurements in the presence or the absence of EIPA as well as in the
presence of different glycolysis and mitochondrial inhibitors to firmly establish
the relationship between the glycolytic flux and the need for proton secretion.
Preliminary resuits obtained by J. Noêl since my departure from the laboratory
are really encouraging and nicely support our hypothesis. The resuits showed
that a treatment of 1NV celis with 50 iM EIPA for different periods of time (0
(DMSO), 30, 60, 90 and 120 mm) decreases by more than 50 ¾ both lactate
production and glucose utilization (data flot shown). This resuit supports the
idea that NHE1 ftmnction is closely linked to the glycolytic flux. The laboratory
will extend the study to include measurements of the metabolic flux (lactate
production) within the purified pseudopod fraction as compared to the total
cellular lactate production. Measurement of lactate production within purified
pseudopodia will also prove that a fttnctional glycolysis occurs in this cellular
compartment independently from the cytoplasm glycolytic enzymes. This resuit
would also add to the originality of the present work.
Identification of MSV-MDCK-INV glucose transporters specially found in the
pseudopodia, alterations in glucose transport kinetics, and studies in the
presence of specific inhibitors of signal transduction components, should get an
important insight into the comprehension of the mechanisms by which glucose
transport is regulated in these ceils, and will indicate the extent to which
deregulation of this transport contributes to the inappropriate migration of NV
ceils.
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The present work brings some hope that glycolysis enzymes of tumor cells will
be in the future a target for pharmaceutical agents to inhibit celi movement, and
so, the metastatic progression of the cancer.
Lactate
figure 3.1: Our hypothesis suggests that under anaerobic conditions glucose
will be metabolized in the pseudopodia via the glycolytic pathway but leading
to lactate production and celi acidification. Based on this hypothesis our model
suggests that lactate wiIl be extruded via a lactate/ proton cotransporter, protons
will be extruded via the Na/H exchanger and ATP will serve to polymerize the
actin and phosphorylate the c-Met receptor. EIPA inhibits the Na7H exchanger
activity and decreases the intracellular pH. In that condition, the high
intracellular H concentration will affect, through retroinhibition, the glycolytic
pathway and decrease the ATP production, which will induce a reduction in c
Met activation and pseudopod protnision.
Glucose
I
EIPA
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